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CHAPTER 1

INTRODUCTION
Parts of this chapter have been published in Biochemica et Biophysica
Acta 1793, 212-218, 2009.

Eukaryotic cells require mitochondria to play a vital role in producing
cellular energy and in the metabolism of amino acids, lipids, heme and iron.
Mitochondria are surrounded by outer and inner membranes, which are made
up of a phospholipid bilayer of unique composition and proteins anchored into
the membrane. Besides acting as glue for the membrane proteins, the
phospholipids play an important role in providing shape to the mitochondria.
Cardiolipin (CL) is the signature phospholipid of mitochondria, which is
synthesized and is predominantly present in the inner membrane. The work in
this thesis identifies key roles of CL in mitochondrial protein import,
mitochondrial fusion and metabolic pathways including the TCA cycle,
glyoxylate cycle and β-oxidation.

1. Structural and physiological role of cardiolipin
Cardiolipin (CL) (1,3 diphosphatidyl-sn-glycerol) is a unique and ubiquitous
anionic phospholipid that, in eukaryotes, is localized primarily in the
mitochondrial inner membrane. CL was first isolated from beef heart, hence
its name (Pangborn, 1948). While it is most abundant in the heart, CL is found
in all mammalian tissues. Unlike the other membrane phospholipids, it has a
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dimeric structure in which two phosphatidyl moieties are linked by a glycerol
(Figure 1.1) (Lecocq and Ballou, 1964). As a result, CL is hydrophobic by
virtue of four fatty acyl groups and acidic due to two phosphates. CL interacts
with a wide variety of mitochondrial proteins by both hydrophobic and
electrostatic interactions (Hoch, 1992; Schlame et al., 2000), and stabilizes
proteins in the mitochondrial respiratory chain (Fry and Green, 1981). CL
molecules can form lamellar or inverted hexagonal structures. The hexagonal
phase is favored in the presence of divalent cations (Vasilenko et al., 1982).
Although the biological relevance of these structures is not known, it is
plausible that CL is involved in the formation of local non-bilayer structures
within biological membranes. Such structures are believed to be involved in
membrane fusion and in trans-bilayer movement of solutes (de Kruijff et al.,
1985). The finding that mitochondrial biosynthesis of the non-bilayer forming
phospholipid phosphatidylethanolamine is essential for the viability of yeast
mutants lacking CL suggests a critical role of CL in the formation of these
structures (Gohil et al., 2005), although it should be noted that these
structures have not been convincingly demonstrated in vivo.
The fatty acid composition of CL plays an important role in the function of the
lipid, as aberrant CL remodeling (replacing one fatty acid with another)
underlies the genetic disorder Barth syndrome (BTHS) (Schlame et al., 2005).
However, no single species of fatty acid is required for function, as the acyl
species of CL from different organisms vary considerably. Bacterial CL
contains saturated and mono-unsaturated fatty acyl chains 14-19 carbons in
length (Kito et al., 1972). Mitochondrial CL is mainly composed of
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Figure 1.1: Structure of cardiolipin (CL): R1, R2, R3, R4 represent fatty
acyl chains.
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monounsaturated and diunsaturated fatty acyl chains of 16-18 carbons in
length, resulting in a much higher unsaturation index than that of bacterial CL.
In mammals and higher plants, the predominant species is linoleic acid,
whereas oleic acid and palmitoleic acid species exist in yeast (Schlame et al.,
1993). In humans, CL acyl species vary with tissue type, although the
predominant species in heart is tetralinoleoyl CL. This species is absent from
BTHS cells (Barth et al., 1999b). While specific CL acyl species vary among
eukaryotic cardiolipin, the feature shared by different organisms is that the
dominant species of CL contains only one or two types of fatty acid. This
leads to symmetry and structural uniformity among CL species (Schlame et
al., 2005).
The most exciting finding pertaining to CL in the last few years is that
this phospholipid plays an important role not only in mitochondrial
bioenergetics, which is not unexpected given the interaction of CL with
mitochondrial proteins, but also in essential cellular functions not generally
associated with respiratory function. Some of these include mitochondrial
protein import, mitochondrial fusion, vacuolar functions, cell wall biogenesis,
translational regulation of electron transport chain (ETC) components, aging,
and apoptosis, and it is likely that this list will be longer in a few years. The
importance of CL in these and other processes is underscored by the finding
that mutations in tafazzin, the CL remodeling enzyme, lead to BTHS. This
chapter focuses on CL biosynthesis and remodeling, cellular functions of CL
and its relevance to BTHS.
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2. CL biosynthesis and remodeling
All of the enzymes for de novo synthesis of CL are present in the
mitochondria. As seen in Figure 1.2, phosphatidylglycerolphosphate (PGP)
synthase (Pgs1p) catalyzes the committed step, forming PGP from CDP-DG
and glycerol-3-phosphate (G-3-P) (Chang et al., 1998a). PGP is then
dephosphorylated to PG by PGP phosphatase Gep4p (PTPMT1 in mammals)
(Osman et al., 2010; Zhang et al., 2011). CL synthase (Crd1p) catalyzes an
irreversible condensation reaction in which CDP-DG is linked to PG via
cleavage of a high-energy anhydride bond to form CL (Chang et al., 1998b;
Hostetler et al., 1971; Hostetler et al., 1972; Jiang et al., 1997; Schlame et al.,
1993; Tamai and Greenberg, 1990; Tuller et al., 1998). CL then undergoes
remodeling in which deacylation by the CL specific deacylase Cld1p leads to
the formation of monolysocardiolipin (MLCL) (Beranek et al., 2009). In rat
liver, mitochondria associated phospholipase A2 was shown to catalyze the
deacylation step to form MLCL (Hauff and Hatch, 2006). MLCL is then
reacylated with another fatty acid (Schlame and Rustow, 1990), which is
catalyzed by tafazzin (Taz1p) (Gu et al., 2004). Schlame et al. demonstrated
that tafazzin is a CoA-independent transacylase that transfers acyl chains
preferentially from phosphatidylcholine (PC) to CL (Schlame and Ren, 2006).
In a study comparing CL species from a wide variety of organisms, Schlame
and co-workers showed that the most abundant species of CL contained only
one or two types of fatty acids, which results in a high degree of structural
uniformity and molecular symmetry in cardiolipin (Schlame et al., 2005). In
contrast, tafazzin-deficient cells were characterized by multiple species of CL.
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Figure 1.2: Biosynthesis and remodeling of CL: PGS1 encodes
phosphatidylglycerol phosphate (PGP) synthase, which converts glycerol-3phosphate (G-3-P) and CDPdiacylglycerol (CDP-DAG) to PGP. PGP is
dephosphorylated to phosphatidylglycerol (PG) by GEP4, which encodes a
PGP phosphatase. CRD1 encodes CL synthase, which converts CDP-DAG
and phosphatidylglycerol (PG) to CL. In the remodeling part of the pathway,
CL is deacylated to monolysocardiolipin (MLCL) by the CL specific
phospholipase Cld1p. MLCL is then reacylated to mature CL by the TAZ1encoded tafazzin.
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The accumulation of MLCL in yeast and human tafazzin-deficient cells
(Claypool et al., 2006; Gu et al., 2004; Valianpour et al., 2005; Vaz et al.,
2003) is consistent with the two-step pathway of remodeling shown in Figure
1.2. BTHS patients display reduced CL, accumulation of MLCL, and aberrant
CL species (Hauff and Hatch, 2006). The importance of remodeling is
underscored by its role in BTHS, a rare X-linked disorder caused by mutations
in tafazzin.

3. CL and BTHS
The CL pathway is crucial for mitochondrial bioenergetics and for essential
cellular functions not generally associated with respiration. It is, therefore, not
surprising that perturbation of this pathway in humans leads to deleterious
consequences. As discussed above, BTHS is a disorder resulting from loss of
the CL remodeling enzyme tafazzin. About ten years after the first description
of BTHS, the locus was mapped to Xq28 (Bolhuis et al., 1991) and mutations
were identified in G4.5, the tafazzin gene (Bione et al., 1996). The link
between CL and BTHS was first reported by Peter Vreken and colleagues,
who demonstrated that fibroblast cultures from BTHS patients contain less CL
than control cultures (Vreken et al., 2000). Furthermore, BTHS cells were
defective in acylation of CL and PG with unsaturated fatty acids. Subsequent
analysis showed that BTHS cells contained a decrease in total CL content
(Vreken et al., 2000) and an accumulation of MLCL (Valianpour et al., 2005).
The predominant acyl species, tetralinoleoyl-CL is absent from BTHS cells
(Barth et al., 1999b).
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Lymphoblast

mitochondria

from

patients

with

BTHS

exhibit

hyperproliferation, impaired coupling, and abnormalities in energy metabolism
(Xu et al., 2005) consistent with studies in tafazzin deficient yeast (Ma et al.,
2004). Due to the adhesion of opposing membranes, the intracrista space in
BTHS mitochondria appears to be deformed (Acehan et al., 2007), which may
explain the decrease in mitochondrial membrane potential in BTHS (Xu et al.,
2005) and in yeast taz1∆ (Ma et al., 2004).
Approximately 28 different mutations resulting in single amino acid
changes in tafazzin have been identified in BTHS patients (Schlame and Ren,
2006). The mutations result in a complete loss of tafazzin or in expression of a
severely truncated protein (Claypool et al., 2006). Interestingly, the clinical
presentation of BTHS varies a great deal, from those who have severe
incapacitating disease to those who are nearly asymptomatic, even among
patients with identical mutations. This variation indicates that physiological
modifiers play a significant role in the BTHS phenotype. Thus, while it is clear
that tafazzin is a CL transacylase, the cellular consequences of defective
tafazzin and the molecular basis underlying the pathologies observed in
BTHS patients are not understood. Homologues of human tafazzin are
present throughout eukaryotic species from yeast to mammals, and yeast
(Claypool et al., 2006; Gu et al., 2004; Vaz et al., 2003), Drosophila (Xu et al.,
2006a), zebrafish (Khuchua et al., 2006) and mouse (Acehan et al., 2011)
models of BTHS have been characterized. Genetic studies in these model
systems will help to elucidate the mechanisms linking tafazzin to the cellular
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defects in BTHS, and to identify the physiological modifiers of the BTHS
phenotype.

4. Yeast as a model system to elucidate the cellular role of CL
The power of the yeast system in elucidating the function of CL derives from
the characterization of the yeast genes that encode Pgs1p, Crd1p, and Taz1p
and the availability of null mutants of these genes (Chang et al., 1998a;
Chang et al., 1998b; Claypool et al., 2006; Gu et al., 2004; Jiang et al., 1997;
Tuller et al., 1998; Vaz et al., 2003). These mutants are powerful molecular
tools to elucidate the role of CL in vivo. The yeast taz1Δ null mutant exhibits
biochemical defects similar to those observed in BTHS (Gu et al., 2004; Li et
al., 2007; Schlame et al., 2002; Valianpour et al., 2003; Vreken et al., 2000).
These defects are complemented by expression of the human tafazzin gene
in the taz1Δ mutant (Ma et al., 2004). Many studies with the yeast mutants
have shown that the CL pathway is required for optimal mitochondrial
function, as discussed below (section 5). The mutants exhibit growth defects
with varying degrees of severity on non-fermentable carbon sources. The
taz1Δ mutant grows poorly on ethanol at elevated temperature (Gu et al.,
2004; Jiang et al., 2000), crd1∆ exhibits growth defects at elevated
temperature on several carbon sources (Jiang et al., 1999; Jiang et al., 2000;
Zhong et al., 2004), and pgs1∆ cannot grow at all on non-fermentable carbon
sources (Chang et al., 1998a; Dzugasova et al., 1998). Interestingly, pgs1Δ
and crd1Δ exhibit growth defects even on glucose, suggesting that the CL
pathway is required for essential cellular processes not directly associated
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with respiration. The crd1Δ mutant exhibits a strain dependent inability to form
colonies at elevated temperature on glucose medium, and pgs1Δ cannot grow
at all at 37oC on glucose unless supplemented with sorbitol (Jiang et al.,
1999; Zhong et al., 2004). Moreover, pgs1Δ also loses mitochondrial DNA,
which may account to some degree for the inability of the mutant to grow on
non-fermentable carbon sources. The studies summarized in section 5
describe cellular functions that are perturbed when CL synthesis is blocked.

5. Cellular functions of CL
As discussed above, the loss of CL in yeast leads to growth defects not only
in non-fermentable but also in fermentable media, indicating that CL is
required for non-mitochondrial functions. Both mitochondrial and nonmitochondrial functions of CL in yeast (Figure 1.3) are discussed in this
section.

5.1 CL and mitochondrial bioenergetics: CL is highly enriched in
membranes designed to generate an electrochemical gradient for ATP
synthesis, such as the bacterial plasma membrane (Dowhan, 1997) and the
inner mitochondrial membrane (Daum, 1985). This ubiquitous and intimate
association between CL and energy transducing membranes suggests an
important role for CL in bioenergetic reactions. CL modulates the catalytic
activities of interacting proteins, such as the ADP–ATP carrier (Beyer and
Klingenberg, 1985) and/or provides stability, as reported for complex III (Fry
and Green, 1980) and complex IV (Sedlak and Robinson, 1999). In vivo
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Figure 1.3: Cellular functions of CL in yeast.
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studies have shown that loss (crd1Δ) and/or decreased CL (taz1Δ) results in
unstable respiratory chain supercomplexes (McKenzie et al., 2006; Pfeiffer et
al., 2003; Xu et al., 2010; Zhang et al., 2005). Unstable supercomplex leads to
leakage of electrons that react with oxygen to form reactive oxygen species
(ROS). Thus, it is possible that an unstable supercomplex increases oxidative
stress that might contribute to the pathogenesis of BTHS. Indeed, during
growth on ethanol as sole source of carbon, both crd1Δ and taz1Δ exhibit an
increase in protein carbonylation, an indicator for increased ROS (Chen et al.,
2008a).

5.2 CL and mitochondrial protein import: More than 98% of mitochondrial
proteins are encoded in the nucleus and synthesized as precursors in the
cytosol.

These

preproteins

are

imported

into

the

mitochondria

via

translocases present in the outer and inner mitochondrial membrane (Pfanner
et al., 1994). The preproteins are targeted to receptor proteins on the outer
mitochondrial membrane and to general import proteins of the TOM complex
(Lill and Neupert, 1996). Transport across the inner membrane is mediated by
the TIM complex (Lill and Neupert, 1996).
A role for CL in protein import was first suggested by the finding that
protein import was blocked when yeast cells were treated with the CL-binding
compound doxorubicin (Eilers et al., 1989). Subsequent studies with the
crd1Δ mutant indicated that the absence of CL leads to a reduced membrane
potential and decreased protein import (Jiang et al., 2000). More recently, a
reconstitution study indicated that the membrane integration of mitochondrial

13

preproteins is most efficient when a presequence translocase is reconstituted
in CL-containing membranes (van der Laan et al., 2007). The import defect
was greater for a preprotein that required a membrane potential.
A link between BTHS and protein import was suggested by the finding
that a BTHS-like illness known as dilated cardiomyopathy with ataxia (DCMA)
syndrome is caused by mutations in the protein import gene DNAJC19/TIM14
(Davey et al., 2006). Like BTHS, DCMA syndrome is characterized by
cardiomyopathy, neutropenia and elevated 3-methylglutaconic acid. The
DNAJC19 protein shares sequence similarity with Tim14p, a protein that is
associated with the inner mitochondrial membrane motor complex of Tim23p.
Because the clinical presentation of DCMA is very similar to that of BTHS, it is
interesting to speculate that the defect in BTHS may be caused or
exacerbated by defective mitochondrial protein import. Studies discussed in
Chapter 2 provide evidence that CL is required for assembly of outer
membrane protein translocases (TOM) (Gebert et al., 2009).

5.3 CL is associated with apoptosis and aging: CL binds specifically and
irreversibly to cytochrome c (Rytomaa and Kinnunen, 1994), limiting the
soluble pool of the protein. Therefore, it may play an important regulatory role
in cytochrome c release, which triggers the downstream events in apoptosis
(Kagan et al., 2005). A role for CL has been implicated in the inter-related
processes of aging and apoptosis (Iverson and Orrenius, 2004; McMillin and
Dowhan, 2002; Pollack and Leeuwenburgh, 2001). Loss of CL in yeast leads
to decreased replicative life span. These defects were rescued by down
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regulating the high osmolarity glycerol stress response pathway or by
promoting cell integrity, suggesting that stress response is perturbed in cells
lacking CL (Zhou et al., 2009).

5.4 Mitochondrial anionic phospholipids and cell wall biogenesis:
Experiments to isolate suppressors of the pgs1Δ temperature sensitivity
phenotype led to the identification of a loss of function mutant of KRE5, a
gene involved in cell wall biogenesis (Zhong et al., 2005). Suppression of
pgs1Δ temperature sensitivity by kre5Δ suggested a connection between the
CL pathway and cell wall biogenesis (Zhong et al., 2005), consistent with the
finding of Lussier et al. that disruption of the PGS1 promoter leads to
hypersensitivity to cell wall perturbing agents such as zymolyase, calcofluor
white, papulacandin and caffeine (Lussier et al., 1997). Biochemical analysis
of the cell wall of pgs1Δ indicated that the mutant has reduced levels of β-1,3glucan (Zhong et al., 2005). Consistent with this, cytological studies revealed
that pgs1Δ cells exhibited the enlarged cell phenotype characteristic of cell
wall mutants. Levels of β-1, 3-glucan were increased in the kre5 suppressor
mutant, and the phenotypes of temperature sensitivity and enlarged spherical
morphology were suppressed by kre5. What are the mechanisms linking
mitochondrial anionic phospholipids to the cell wall, from which these lipids
are absent? A clue to this question comes from the finding that cell wall
defects in the pgs1Δ mutant are associated with perturbation of the cell
integrity pathway (Zhong et al., 2007). In this pathway, activation of Pkc1p in
response to cell wall stress results in activation of a cascade of proteins in the
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Mpk1/ Slt2 mitogen activated protein kinase (MAPK) pathway, culminating in
the activation/dual phosphorylation of Slt2. The dual phosphorylated Slt2p
activates transcription factors that up-regulate genes involved in cell wall
synthesis (Jung and Levin, 1999; Terashima et al., 2000). Interestingly, the
pgs1Δ mutant exhibits defective Slt2p activation, which is restored by the kre5
suppressor (Zhong et al., 2007). The mechanism linking PG/CL to the Slt2
pathway is not known.

5.5 CL, inositol sphingolipid phospholipase C (Isc1p), and translational
regulation of electron transport chain (ETC) components: Dowhan et al.
made the surprising observation that pgs1Δ exhibits defective translational
regulation of several mitochondria-encoded ETC components and of Cox4p, a
nuclear-encoded component of the ETC (Ostrander et al., 2001). The
translational defect resulted from the lack of PG/CL in the mitochondrial
membrane, as re-introduction of PGS1 on a high copy plasmid restored
expression of Cox4p. RNA levels were not affected, and in vitro studies
indicated that the defect was not due to decreased protein import but rather to
a failure of translation (Su and Dowhan, 2006). Deletion analysis of the
upstream non-coding region of COX4 suggested that a cis-acting sequence
with two stem-loops in the 5′ UTR appeared to be responsible for inhibition of
COX4 translation. Trans-acting factors that bind to this region have not been
identified; however, binding of a protein factor(s) to this sequence was
observed with cytoplasm from pgs1Δ but not wild type PGS1 cells, and loss of
function mutants that allowed expression of reporter constructs under control
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of the COX4 promoter were isolated. These findings identify a novel cross talk
pathway between mitochondria and the nucleus, in which translation of
nuclear-encoded proteins destined for the mitochondrial membrane respond
to a deficiency of mitochondrial anionic lipids PG and/or CL (Su and Dowhan,
2006).
Defective translation of Cox4p was also seen with the loss of inositol
phosphosphingolipid phospholipase C (Isc1p), a member of the family of
neutral sphingomyelinases that regulate ceramide synthesis. Isc1p is
localized to the mitochondrial outer membrane. Its activity is impaired in the
pgs1Δ mutant, suggesting that PG/CL is required for activation of this enzyme
(Vaena de Avalos et al., 2005). Interestingly, the phenotypic defects of isc1Δ
and pgs1Δ are similar, which suggests that these genes may have
overlapping functions. These findings led to the speculation that PG regulates
translation of the ETC proteins indirectly by activation of Isc1p.

5.6 CL and the vacuole: Recent studies provide interesting evidence that the
loss of CL affects vacuolar function. The loss of CL leads to vacuolar defects,
including swollen vacuolar morphology and loss of vacuolar acidification at the
non-permissive temperature (Chen et al., 2008b). Consistent with this, the
crd1Δ mutant showed decreased vacuolar H (+)-ATPase activity and proton
pumping. Deletion of NHX1, which is required for Na+ and K+ ion exchange,
and for vacuolar fusion, alleviates the temperature sensitive (ts) phenotype of
crd1Δ, suggesting that vacuolar function is essential for survival of crd1Δ.
Interestingly, deletion of RTG2, a sensor for mitochondrial dysfunction, also

17

rescues the ts phenotype and defects in vacuolar morphology of crd1Δ mutant
cells (Chen et al., 2008b). The role of CL in the cross talk between vacuole
and mitochondria is yet unknown.

5.7 CL and the cell cycle: The loss of mitochondrial DNA in cells lacking CL
leads to elevated expression of the morphogenesis checkpoint protein Swe1p
(Chen et al., 2010b). The elevated expression of Swe1 is most likely due to
activation of the retrograde pathway, as deletion of RTG2 and RTG3 rescues
the elevated expression of Swe1. In addition, deletion of Swe1 in rho0 cells of
the crd1Δ mutant rescues the cell cycle defect (Chen et al., 2010b). The
mechanistic link between CL and the cell cycle has not been elucidated.

6. Project outline
The objective of the studies described in this thesis is to understand
the cellular functions of CL that may identify physiological modifiers of BTHS.
Utilizing power of yeast genetics, I showed that CL is required for
mitochondrial protein import (Chapter 2), mitochondrial fusion (Chapter 3),
and the mitochondrial retrograde pathway (Chapter 4).
As discussed above, BTHS is caused by mutations in tafazzin. BTHS
patients exhibit a wide range of clinical symptoms, indicating that
physiological modifiers influence the BTHS phenotype. Based on these
observations, I hypothesized that the identification of synthetic lethal
interactions with CL mutants will identify potential physiological modifiers.
Using yeast as my model system, a targeted synthetic lethality screen was
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performed with the CL mutants to identify genes that share common
pathway/functions with CL. These studies showed that CL mutants genetically
interacted with several mutants of mitochondrial protein import and
mitochondrial morphology. Studies in Chapter 2 describe the role of CL in
protein import and in the maintenance of mitochondrial morphology.
Previous findings have reported that cells lacking both CL and
mitochondrial PE are inviable, suggesting an overlapping role of these
phospholipids.

Because

these

lipids

affect

membrane

curvature,

I

hypothesized that they have overlapping roles in mitochondrial fusion. The
studies in Chapter 3 show that the loss of both CL and mitochondrial PE leads
to highly fragmented mitochondria caused by defective mitochondrial fusion.
These results strongly suggest that CL and mitochondrial PE have
overlapping functions in mitochondrial fusion and are required to maintain
tubular mitochondrial morphology. Thus, Chapter 3 identifies a specific role of
CL in mitochondrial fusion, which could be a modifier of tafazzin deficiency in
BTHS.
Chapter 4 identifies a role of CL in essential metabolic pathways,
including the TCA cycle, β-oxidation pathway and the glyoxylate cycle. Recent
findings from the Greenberg lab showed that the loss of CL leads to
decreased activities of TCA cycle enzymes aconitase and succinate
dehydrogenase (Vinay Patil, unpublished). A block in the TCA cycle leads to
activation of the mitochondrial retrograde (RTG) pathway in WT cells. The
studies in Chapter 4 test my hypothesis that crd1Δ exhibits defective
activation of the RTG pathway at elevated temperature. Consistent with this
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prediction, I report that the loss of CL leads to metabolic defects that are not
alleviated due to defect in activation of the RTG pathway.
While the studies described here identify fascinating cellular functions
of CL, many questions remain unanswered. Future studies to elucidate the
mechanisms whereby CL affects these functions are suggested in Chapter 5.
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CHAPTER 2

GENETIC SCREEN TO IDENTIFY PHYSIOLOGICAL MODIFIERS THAT
EXACERBATE THE LOSS OF CARDIOLIPIN IN S. CEREVISIAE

Parts of this chapter have been published in Current Biology 19(24): 2133-9,
2009. I thank Gnanada Kulkarni and Naomi Fei for assistance with tetrad
dissection.

INTRODUCTION

Barth Syndrome (BTHS) is a rare X-linked disorder characterized by
cardiomyopathy, skeletal myopathy, neutropenia, 3-methylglutaconic aciduria
and growth retardation due to abnormal mitochondria and defective oxidative
phosphorylation (Barth et al., 1981). Other metabolic abnormalities found in
patients include elevated urinary excretion of 3-methylglutaconic acid
(Cardonick et al., 1997) and hypocholesterolemia (Mazzocco et al., 2007).
About ten years after the first description of BTHS, mutations were identified
in G4.5, commonly referred to as tafazzin (TAZ1) (Bione et al., 1996).
Mutations result in the complete loss of Taz1p or in expression of a severely
truncated Taz1p (Bione et al., 1996). The characteristic symptoms of BTHS
vary widely, even among patients with identical mutation, and there is
considerable variation in the age of onset and in disease progression (Barth et
al., 2004). Cardiomyopathy is a characteristic feature and primary cause of
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death in BTHS patients (Barth et al., 1999a). Cardiomyopathy is a structural
disease of the heart muscle that is marked by rigidity and loss of flexibility of
the heart walls, leading to weakness and fatigue (Barth et al., 1983). Skeletal
myopathy and cardiomyopathy lead to delayed motor development in some
BTHS patients, and to changes in cardiac mitochondrial appearance (Xu et
al., 2006a). Skeletal myopathy and cardiomyopathy are due to muscle
weakness, which can be related to deficient oxidative phosphorylation (Barth
et al., 1999b). Sudden neutropenia, an abnormally low number of neutrophils,
is a major cause of death in BTHS patients due to bacterial infections (Barth
et al., 2004). Neutropenia in BTHS is cyclic, and thus not always detectable,
but it is a major cause of concern as it often leads to chronic bacterial
infections. 3-methylglutaconic aciduria (3-MGA) in the urine of BTHS patients
is caused by deficiency of the enzyme 3-methylglutaconyl-CoA hydratase,
involved in the mitochondria localized leucine degradation pathway (Schmidt
et al., 2004).
As mentioned, the clinical symptoms of BTHS vary among patients
even those with identical mutations (Gonzalez, 2005). These range from
severe incapacitating disease to those who are nearly asymptomatic
(Gonzalez, 2005). The cellular function of Taz1p and the molecular basis
underlying the pathologies observed in BTHS patients are not well
understood. Peter Vreken and colleagues demonstrated that fibroblast
cultures from BTHS patients contain less CL than control cultures (Vreken et
al., 2000). Furthermore, BTHS cells were defective in acylation of CL and PG
with unsaturated fatty acids. Subsequent analysis showed that BTHS cells

22

contained a decrease in total CL content (Vreken et al., 2000) and an
accumulation of MLCL (Valianpour et al., 2005). The predominant acyl
species, tetralinoleoyl-CL, is absent from BTHS cells (Schlame et al., 2003).
The role of tafazzin is highly conserved from yeast to humans. To
elucidate the role of tafazzin in BTHS, the Greenberg lab has developed a
yeast model for the disorder (Gu et al., 2004). The taz1∆ mutant, a null mutant
of tafazzin, has decreased CL, increased MLCL, and aberrant acyl species,
similar to the biochemical profile in BTHS. These defects are complemented
by expression of the human TAZ1 cDNA (Ma et al., 2004). Therefore, the
yeast model for BTHS is a powerful tool for in vivo studies of tafazzin function.
To elucidate the function of tafazzin and identify the physiological factors that
exacerbate its loss, we used the powerful genetic tool of synthetic lethality.
Synthetic lethal analysis exploits the possibility that two non-lethal mutations
in genes that provide an essential function lead to an inviable cell when
present together (Hartman et al., 2001). An example of this is demonstrated
by previous studies in the lab, which have identified a synthetic lethal
interaction between the genes for mitochondrial phosphatidylethanolamine
(PE) synthesis and CL synthase (Gohil et al., 2005). This study indicated that
mitochondrial biosynthesis of PE is essential for yeast crd1∆ cells, which lack
CL.
In this chapter, I report a screen for synthetic lethality with crd1Δ and
taz1Δ, screening target genes that represent pathways relevant to the clinical
presentation in BTHS patients. Several mutants from functional categories
such as mitochondrial protein import and mitochondrial morphology exhibited
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synthetic lethal or synthetic sick phenotypes with the CL mutants, suggesting
a possible overlapping role of CL in these mitochondrial functions. Consistent
with the prediction, we show that CL is required for outer membrane protein
biogenesis (Gebert et al., 2009). In addition, the following chapter (Chapter 3)
shows that CL is also required for mitochondrial fusion (Joshi et al., 2012).
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Materials and methods

Yeast strains and growth media:
The yeast strains used in this study are isogenic to BY4741 and BY4742.
Complex medium (YP) contained 1% yeast extract (US Biological), 2%
peptone (Fischer Scientific) and 2% glucose (Fischer Scientific) in YPD and
3% glycerol (EMD) in YPG. Complete synthetic medium (CSM) contained
adenine (20.25 mg/liter), arginine (20 mg/liter), histidine (20 mg/liter), leucine
(60 mg/liter), lysine (200 mg/liter), methionine (20 mg/liter), threonine (300
mg/liter), tryptophan (20 mg/liter), and uracil (20 mg/liter), vitamins, salts
(essentially components of Difco Vitamin Free Yeast Base without amino
acids), and glucose (2%). Synthetic drop out medium contained all of the
above ingredients except the amino acid used as a selectable marker.
Sporulation medium contained potassium acetate (1%), glucose (0.05%), and
the essential amino acids. Solid medium was prepared by adding 2% agar.

Construction of double mutants by tetrad dissection:
The CL mutants crd1Δ::URA3 and taz1Δ::URA3 MATα/MATa were crossed
with mutants of opposite mating type obtained from the yeast deletion
collection. The heterozygous diploids were selected on dropout media lacking
methionine and lysine, sporulated, and tetrads were dissected. The synthetic
interaction between CL and deletion mutants was determined by examining
the growth of the double mutant compared to isogenic parent strains and wild
type on YPD.

25

Extraction, separation and analysis of yeast total phospholipids:
Yeast cells were grown in the presence of

32

Pi (10 µCi/ml) in the indicated

growth conditions. Total phospholipids were extracted and analyzed by TLC
as described (Vaden et al., 2005). The developed chromatograms were
analyzed by phosphorimaging and the phospholipids were quantified using
Image Quant software.

Fluorescence microscopy:
Fluorescence

microscopy

was

performed

using

an

Olympus

BX41

epifluorescence microscope. Images were acquired using an Olympus QColor3 digitally charge-coupled device camera operated by QCapture2
software. All pictures were taken at 1,000 X. To stain mitochondrial DNA,
yeast cells were cultured to the mid-log phase, fixed in 70% ethanol at room
temperature for 30 min, washed two times with distilled water, and stained
with 1 µg/ml DAPI (Sigma) for 5 min.
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Results

Acyltransferase and sterol metabolism mutants are not synthetically
lethal with CL mutants
The

first

group

tested

for

synthetic

lethality

with

taz1Δ

was

the

acyltransferases. Tafazzin is a transacylase that remodels CL (Xu et al.,
2006b). We hypothesized that other acyltransferases or their products could
compensate for the loss of TAZ1. Loss of these compensatory enzymes or
products might thus be lethal in a TAZ1 deficient cell. The second group
tested for synthetic lethality with CL mutants was sterol metabolism. The
sterol metabolism pathway is relevant because hypocholesterolemia is a
prevalent clinical abnormality in BTHS (Spencer et al., 2006). Sterols are a
vital component of mitochondrial membranes. In addition to this, sterol
synthesis is highly conserved in yeast and mammals (Guo et al., 2001;
Hampton et al., 1996; Lees et al., 1999). Therefore, we hypothesized that loss
of sterol might be lethal in taz1∆, as the loss might exacerbate defective
mitochondrial function. To test these hypotheses, we crossed nine
acyltransferase mutants (Table 2.1) and three sterol metabolism mutants
(Table 2.2) obtained from the deletion collection with the taz1Δ mutant, and
performed tetrad analysis. In all twelve crosses, the double mutants (CL
mutant and sterol or acyltransferase mutant) were viable, indicating that the
taz1∆ mutant is not synthetically lethal with acyltransferase or sterol
metabolism mutants (Tables 2.1 and 2.2).
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Table 2.1: Genetic interaction of acyltransferase mutants with taz1∆. The
acyltransferase mutants in the MATa genetic background were crossed with
the taz1Δ mutant (MATα) to obtain double mutants. Genetic interaction was
determined based on the viability of the double mutant. Inviable double
mutants would suggest a synthetic lethal interaction; viable double mutants
with growth defects would indicate a synthetic sick interaction, and double
mutants with no growth defect would indicate no genetic interaction. No
genetic interactions were found in these crosses.

Acyltransferase mutants

Number of tetrads dissected

slc1∆
are1∆
lro1∆
dga1∆
sct1∆
gpt2∆
mum3∆
YBR042C∆
YDR018C∆

18
20
25
16
15
16
20
20
18

Genetic
interaction
No
No
No
No
No
No
No
No
No

Table 2.2: Genetic interaction of sterol metabolism mutants with taz1∆.
The sterol metabolism mutants were crossed with the taz1Δ mutant to obtain
double mutants. Genetic interaction was determined as in Table 2.1. No
genetic interaction was found.
Sterol metabolism
mutants
atf1∆
osh6∆
izh4∆

Number of tetrads dissected
18
17
18

Genetic
interaction
No
No
No
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CL is required for assembly of the outer mitochondrial membrane
protein complex
Previous studies in the Greenberg lab suggested that CL is required for
mitochondrial protein import at elevated temperature (Jiang et al., 2000).
Interestingly, a BTHS-like illness known as dilated cardiomyopathy with ataxia
(DCMA) syndrome is caused by mutations in the protein import gene
DNAJC19/TIM14. These findings strongly suggest that the defect in BTHS
may be caused or exacerbated by defective mitochondrial protein import. To
test this possibility, we screened mutants of the outer and inner mitochondrial
membrane complexes for genetic interactions with crd1∆ and taz1∆. The
outer mitochondrial membrane consists of TOM, SAM and MDM complexes
(Figure 2.1). The TOM machinery is made up of at least seven subunits: the
channel forming unit Tom40p, the receptor components Tom22p, Tom20p,
and Tom70p, and small Tom proteins Tom5p, Tom6p, and Tom7p (Bolender
et al., 2008). The TOM complex is involved in the import of some outer
membrane precursors, but whether it is required for import and assembly of
all outer membrane proteins is unclear (Rapaport, 2003). The SAM complex is
required for the insertion of ß-barrel proteins in the outer membrane (Kozjak
et al., 2003). As seen in Figure 2.2, the double mutants exhibited a range of
phenotypes. The crd1∆tom5∆ and crd1∆mdm12∆ mutants were synthetically
lethal. The tom5∆ mutant was also lethal with taz1Δ. The mutants tom70∆,
tom7∆, mdm10∆, mdm12∆, mmm1∆, sam37∆ were synthetically sick with
crd1∆ and taz1∆, as double mutants grew at 300C but not at elevated
temperatures. Double mutants tom6∆crd1∆ and tom6∆taz1∆ grew similar to
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Figure 2.1: Mitochondrial protein import machinery. Nuclear encoded
proteins are imported into the mitochondria via the translocase of the outer
membrane (TOM) and two translocases of the inner membrane (TIM22 and
TIM23). The presequence directs preproteins to the TOM complex at the
outer membrane, then to the TIM23 and PAM complexes at the inner
membrane. Carrier (transporter) proteins with internal target sequences are
targeted to Tom70, and then inserted into the inner membrane by the TIM22
complex (Bolender et al., 2008).

30

Figure 2.2: Genetic interactions and synthetic growth defects. Cells were
grown at 300C in liquid YPD to the early stationary phase, serially diluted,
spotted on YPD plates, and incubated at the indicated temperatures for 3 to 5
days.
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WT. The growth defects in import mutants were more severe with crd1Δ than
taz1∆, supporting the hypothesis that the defects were due to CL. The genetic
interactions of TOM, SAM and MDM complex mutants with the taz1∆ mutant
suggest that aberrant CL species (lacking unsaturated fatty acids), increased
MLCL or decreased CL in the taz1Δ mutant was insufficient to fully support
the function of CL in mitochondrial protein import. The genetic interactions of
the CL mutants were observed not only with the TOM complex (Table 2.3) but
also with the SAM and MDM (Table 2.4) complexes, which are involved in the
assembly of outer membrane β-barrel proteins, suggesting that CL is required
for the assembly of these proteins. In collaboration with Dr. Nikolaus Pfanner
(University of Freiburg), we revealed a new role for CL in protein sorting at the
outer mitochondrial membrane (Gebert et al., 2009).

CRD1 genetically interacts with TIM and PAM complexes
Pre-proteins translocated from the TOM complex are directed to the inner
membrane translocase, the Tim23p complex (Bauer et al., 1996). An alternate
pathway for insertion of inner membrane proteins (transporter proteins) is the
carrier pathway mediated by the Tim22p complex. To identify the function of
CL in inner mitochondrial protein import, we crossed the available deletion
mutants from the Tim23 and Tim22 complexes, mitochondrial intermembrane
space import and assembly machinery (MIA) complex, presequence
translocase-associated motor (PAM) complex that is associated with Tim23,
and chaperones of intermembrane space (small TIM proteins) complexes with
the CL mutants (Figure 2.1).
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Table 2.3: Genetic interaction of CL mutants with the TOM complex. The
TOM complex mutants were crossed with the CL mutants to obtain double
mutants. The genetic interaction was determined based on the viability of the
double mutants. Key: (-): no growth; (+/-): poor growth; (+): good growth.
Mitochondrial protein import
mutants

Growth of double mutants
taz1Δ

crd1Δ

300C

380C

300C

380C

tom5∆

-

-

-

-

tom6∆

+

+

+

+

tom7∆

+

+

+/-

+/-

tom70∆

+

+/-

+/-

+/-

Table 2.4: Genetic interaction of CL mutants with the SAM and MDM
complexes. The SAM and MDM complex mutants were crossed with the CL
mutants to obtain double mutants. The genetic interaction was determined
based on the viability of the double mutants. Key: (-): no growth; (+/-): poor
growth; (+): good growth.
Mitochondrial protein import
mutants

Growth of double mutants
taz1Δ

crd1Δ

0

30 C

0

37 C

0

30 C

370C

+

+/-

+/-

-

0

30 C

0

36 C

0

30 C

360C

+

+/-

+

+/-

0

30 C

0

38 C

0

30 C

380C

mdm12∆

+/-

-

-

-

mmm1∆

+

+/-

+

+/-

mdm10∆
sam37∆
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TIM23 and PAM complexes: The Tim23p complex mediates a membrane
potential and ATP driven import of proteins across the mitochondrial inner
membrane (Truscott et al., 2001). This complex, along with mtHsp70 and the
PAM complex, drive the import of the preprotein into the matrix in an ATP
dependent manner (Krayl et al., 2007). An alternative route for import of
proteins by the TIM23 complex includes Tim17p and Tim21p (Figure 2.1).
This pathway is independent of function of mtHsp70 and ATP (Chacinska et
al., 2005). Even though the CL mutants did not genetically interact with the
tim21Δ mutant from the Tim23 complex, the crd1Δ mutant was synthetic sick
with pam17Δ (Table 2.5). Pam17p modulates the function of the core Tim23
complex by affecting its conformation (van der Laan et al., 2005). The genetic
interaction studies indicate that CL might affect the assembly of TIM23 by
affecting the function of the PAM complex. Our studies indicate that CL is
specifically required for the ATP and membrane potential dependent functions
of the TIM23 complex.
TIM22 complex: The TIM22 complex is required for insertion of hydrophobic
proteins, usually carrier proteins such as the ADP/ATP carrier (transporters)
(Wiedemann et al., 2001). The import pathway that involves the TIM22
complex is, thus, termed the carrier pathway. The TIM22 complex core
consists of Tim22p, Tim54p, Tim18p, and Sdh3p (Figure 2.1). The core of the
TIM22 complex is associated with small TIM proteins (Tim9p, Tim10p,
Tim12p) from the intermembrane space (Figure 2.1). The small TIM proteins
facilitate the transit of proteins during import from the outer membrane
complex (TOM) to the inner membrane complex (TIM22) (Curran et al., 2002).
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Table 2.5: Genetic interaction of CL mutants with mitochondrial inner
membrane protein import complexes. The TIM and PAM complex mutants
were crossed with the CL mutants to obtain double mutants. The genetic
interaction was determined based on the viability of the double mutants. Key:
(-): no growth; (+/-): poor growth; (+): good growth.

Mitochondrial
protein import
mutants

Growth of double mutants
taz1Δ

crd1Δ

0

30 C

0

37 C

0

30 C

370C

hot13Δ

+

+

+

+

tim13Δ

+

+

+

+

tim18∆

+

+

-

-

pam17Δ

+

+

+/-

+/-

tim21∆

+

+

+

+
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Interestingly, the tim18Δ mutant was synthetically lethal with crd1Δ but not
with taz1Δ (Table 2.5). These results indicate that the complete loss of CL, as
in crd1Δ, affects the function of the TIM22 complex while the presence of
decreased levels of CL, aberrant CL species or increased MLCL, as in the
taz1Δ mutant, are sufficient to support Tim22 function. Tim18p is a subunit of
Tim22 complex that assembles with Sdh3p to function in protein biogenesis
(Gebert et al., 2011). In addition to the synthetic lethal interaction between
crd1Δ and tim18Δ, recent studies have shown that the loss of CL leads to
decreased activity of the SDH complex (Vinay Patil, unpublished), indicating
that CL is required for the function of the subunits of the TIM22 complex.
MIA complex and small TIM proteins: The MIA complex proteins Mia40p
and Erv1p, along with Hot13p, stabilize proteins imported from the TOM
complex and relay them to the small TIM proteins or to the TIM22 complex
(Curran et al., 2002; Rissler et al., 2005). The crd1Δ and the taz1Δ mutants
did not genetically interact with the available deletion mutants, including
hot13Δ, from the intermembrane space MIA complex, and the small TIM
protein mutant tim13Δ (Table 2.5). These findings strongly suggest that the
function of CL is limited to the membrane proteins required for mitochondrial
protein import.

Deletion of mitochondrial morphology genes exacerbates the growth
defect in crd1Δ
CL is involved in mitochondrial membrane structure and stability due to its
unique physical properties. This structurally unique lipid assembles in the
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presence of divalent cations as inverted hexagonal structures (Vasilenko et
al., 1982). Recent studies have demonstrated that CL is required for
maintaining mitochondrial morphology (Kuroda et al., 2011b; Osman et al.,
2009b; Tamura et al., 2009). We recently demonstrated a specific function of
CL in mitochondrial fusion (Chapter 3) (Joshi et al., 2012). Mitochondria from
cells with mutated tafazzin exhibit abnormal mitochondrial morphology, further
supporting a role for CL in mitochondrial morphology (Acehan et al., 2011;
Acehan et al., 2007; Xu et al., 2005). The lack of CL could indirectly affect
morphology due to reduced mitochondrial functions such as defective
mitochondrial protein import and loss of mitochondrial DNA. Therefore, we
hypothesized that deletion of genes with functions related to maintenance of
mitochondrial morphology would exacerbate the growth defects of cells
lacking CL. To characterize the function of CL in mitochondrial morphology,
we performed a targeted synthetic lethality screen assessing genetic
interactions between mutants lacking CL and mutants in mitochondrial
morphology. The genetic screen in the current study identified both lethal and
sick interactions. The genes that affect mitochondrial morphology are grouped
according to their individual functions in Table 2.6.
UPS proteins: Ups1p was first shown to mediate processing of Mgm1p, an
inner mitochondrial membrane protein required for mitochondrial fusion, to
small and long isoforms (Sesaki et al., 2006). Recent findings have shown
that Ups1 and Ups2 proteins regulate the levels of mitochondrial PE and CL
Table 2.6: Genetic interaction of CL mutants with mitochondrial
morphology mutants. Mitochondrial morphology mutants were crossed with
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crd1Δ to obtain double mutants. Key: (-): No growth; (+/-): poor growth; (+):
good growth.
Mitochondrial morphology mutants

crd1∆
300C

370C

ups1∆

-

-

ups2∆

-

-

ups3∆

+

+

get1∆

+

+/-

get2∆

+/-

+/-

get3∆

+

+/-

mdm31∆

+

+

mdm32∆

+

+

ERMES complex

gem1∆

+/-

+/-

F-box protein association

mfb1∆

+

+

Imported protein cleavage

cym1∆

+

+/-

Fatty acid synthesis

htd2∆

+

+/-

Similarity to hemolysins

mam3∆

+

+/-

Mitochondrial dynamics

dnm1∆

+/-

-

fis1∆

+

+

mdv1∆

+

+

mdm36∆

+

+/-

ugo1∆

-

-

fzo1∆

-

-

mgm1∆

+

+

UPS protein

GET complex

Mitochondrial inheritance
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Figure 2.3: crd1Δ is synthetically lethal with ups1Δ. A diploid strain
heterozygous for deletion of CRD1 and UPS1 was sporulated, and tetrads
were dissected and incubated on YPD for 3-4 days at 30°C. Tetrads 1,3,6 and
7 are tetratype asci, and 2,4 and 5 are parental ditypes. Arrows indicate
inviable double mutant haploid spores.
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(Tamura et al., 2009). Thus, to determine if UPS proteins and CL have
overlapping cellular functions, we tested if UPS mutants genetically interacted
with crd1Δ. As seen in Figure 2.3, CRD1 is synthetically lethal with UPS1, as
crd1Δups1Δ is not viable. Earlier studies showed that the ups1Δ mutant has
seven-fold decreased levels of CL (Osman et al., 2009a). We demonstrate
here that CL is essential for viability of the ups1Δ mutant. Consistent with
earlier studies (Osman et al., 2009a), we observed synthetic lethality between
crd1Δ and ups2Δ. The synthetic lethality is very likely due to the decreased
PE levels in ups2Δ (Osman et al., 2009a; Tamura et al., 2009), as our
previous studies showed that synthesis of mitochondrial PE is essential in
cells lacking CL (Gohil et al., 2005). UPS1 and UPS2 antagonistically regulate
CL levels, affect the assembly of mitochondrial protein import complexes such
as TIM23, which is present in the inner membrane, and regulate mitochondrial
morphology (Tamura et al., 2009). The mechanism by which UPS1 and UPS2
regulate CL levels remains unknown.
GET complex: The second group of mutants that interact with CRD1 is the
GET complex. Recent studies have suggested that the GET complex is
required for targeting newly synthesized tail-anchored (TA) proteins to the ER
membrane. This process involves formation of the Get3p-TA complex in the
cytosol, which is then recruited by the Get1/2p receptor proteins present in the
ER membrane to insert the TA proteins in the lipid bilayer (Mariappan et al.,
2011; Schuldiner et al., 2008; Stefer et al., 2011; Wang et al., 2011). Both
crd1Δget1Δ and crd1Δget3Δ exhibited growth defects compared to the parent
strains (Figure 2.4). In contrast, genetic interaction was not observed between
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Figure 2.4: crd1Δ is synthetically sick with get1Δ and getΔ3. Yeast cells
were pre-cultured overnight in YPD at 30°C, serially diluted and spotted on
YPD plates. The plates were incubated at 30°C and 37°C for 3-4 days.
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crd1Δ and get2Δ. These findings suggests that at elevated temperature, CL is
essential for the growth of get1Δ and get3Δ but not get2Δ, or that the function
of Get1p or Get3p, but not Get2p, is essential for growth of crd1Δ. These
findings may indicate that CL shares a novel essential function with Get1p
and Get3p but not with Get2p.
Surprisingly, the GET complex mutants get1Δ and get2Δ, but not
get3Δ, exhibited a decrease in CL levels (~25% and ~55%, respectively)
compared to WT (Figure 2.5, Table 2.7). This is the first demonstration that
ER membrane receptor proteins Get1p and Get2p regulate the levels of CL.
While the loss of mitochondrial DNA leads to a decrease in CL (Chen et al.,
2010b), this cannot explain the reduced CL levels in get1Δ and get2Δ, as
DAPI staining indicated the presence of mitochondrial DNA (mtDNA) in the
GET mutants (Figure 2.6). Although the GET mutants were not deficient in
mtDNA, they exhibited a severe growth defect in respiratory medium,
indicating reduced mitochondrial function (Figure 2.7). These results indicate
that import of precursors of CL or enzymes required for CL biosynthesis in the
mitochondria might be affected in the get1Δ and get2Δ mutants. Our results
clearly identify a new role for the GET complex in regulating the levels of CL
and mitochondrial function.
MDM proteins and GEM1: An independent study demonstrated synthetic
interactions between crd1Δ and MDM complex mutants mdm10Δ, mmm1Δ,
mdm12Δ and mdm34Δ, consistent with our finding (Table 2.4) (Gebert et al.,
2009), which led to identification of the ER-mitochondria tethering complex
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Figure 2.5: Separation of phospholipids from get1Δ, get2Δ and get3Δ
mutants. Yeast cells were grown in YPD containing

32

Pi at 30°C to the early

stationary phase. Total phospholipids were extracted and analyzed by onedimensional TLC as described (Vaden et al., 2005).
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Table 2.7: Quantitation of CL in the GET and the mitochondrial fusion
complex mutants. Yeast cells were grown in YPD with 32Pi at 30°C until early
stationary phase. Total phospholipids were extracted and analyzed by 1DTLC as described (Vaden et al., 2005). Values indicated represent mean ±
S.D (n=2) for GET mutants and ± S.E (n=3) for fusion mutants.
Strains

% CL (Mean ± S.D)

Strains

% CL (Mean ± S.E)

WT

100

WT rho zero

100

get1Δ

77.7 ± 4.7

mgm1Δ

89.6 ± 12.7

get2Δ

45.3 ± 0.7

ugo1Δ

32.0 ± 15.5

get3Δ

90.7 ± 9.3

fzo1Δ

134.4 ± 18.11
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Figure 2.6: The get1Δ, get2Δ and get3Δ mutants do not exhibit loss of
mitochondrial DNA. Yeast cells were cultured to the mid-log phase, fixed in
70% ethanol at room temperature for 30 min, washed two times with distilled
water, and stained with 1 µg/ml DAPI (Sigma) for 5 min. Arrows indicate
mtDNA.
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Figure 2.7: GET complex mutants exhibit decreased mitochondrial
function. Yeast cells grown in liquid YPD for 1 day were inoculated into liquid
YPG to an A550 of 0.1 and grown at 300C with shaking at 230 rpm. Aliquots of
each culture were taken and cell density was measured at A550.
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(ERMES). The ERMES complex was shown to be involved in phospholipid
exchange, mitochondrial protein import, maintenance of mitochondrial DNA
and morphology (Kornmann et al., 2009). In a recent finding, Kornmann et al.
suggested that Gem1p is an integral component of the ERMES complex. It
was shown to regulate the number and size of ERMES complexes and
mediate phospholipid exchange. Consistent with this study, we showed that
crd1Δ genetically interacts with gem1Δ (Table 2.6), supporting the function of
the ERMES complex in phospholipid exchange (Kornmann et al., 2011).
Mitochondrial dynamics: CRD1 genetically interacted with genes involved in
mitochondrial

fusion

and

fission.

CRD1

is

synthetically

lethal

with

mitochondrial fusion genes UGO1 and FZO1 (Table 2.6). The fzo1Δ mutant
also exhibited synthetic interaction with fmp30Δ, a mitochondrial inner
membrane protein required for maintaining mitochondrial morphology and
regulating CL levels (Kuroda et al., 2011b). To determine if fusion genes
regulate CL levels, we examined CL levels in the fusion mutants. Because
loss of mitochondrial DNA leads to decreased CL (Chen et al., 2010b) and
fusion mutants lose mitochondrial DNA (Guan et al., 1993; Hermann et al.,
1998; Nunnari et al., 1997), we compared CL levels of fzo1Δ, ugo1Δ and
mgm1Δ with WT rho0 cells. Except for ugo1Δ, fusion mutants did not exhibit a
significant decrease in CL levels (Table 2.7). CRD1 also specifically interacted
with the DNM1 and MDM36 genes in the fission pathway, as the dnm1Δ and
mdm36Δ mutants exhibited synthetic interaction with crd1Δ (Table 2.6). DNM1
is involved in mitochondrial fission, participates in endosomal trafficking, and
regulates peroxisome abundance (Gammie et al., 1995; Kuravi et al., 2006;
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Otsuga et al., 1998), while MDM36 is suggested to promote mitochondrial
fission (Hammermeister et al., 2010). Genetic interaction of the mitochondrial
dynamics mutants with crd1Δ strongly suggests that CL is required for
maintaining mitochondrial morphology.
Other mitochondrial morphology genes: CRD1 also genetically interacted
with CYM1, HTD2, and MAM3, suggesting that these genes have overlapping
functions with CRD1 in common essential cellular pathways (Table 2.6). The
genetic screen has provided evidence that point towards specific players
required for regulation of CL levels and mitochondrial function in yeast.
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Discussion

In this study, a targeted genetic screen was performed in S. cerevisiae to
identify the cellular functions of CL that might be potential physiological
modifiers of BTHS. We identified genetic interactions between CL mutants
and mutants from mitochondrial protein import complexes (TOM, SAM, MDM,
TIM and PAM) and mutants with defective mitochondrial morphology (the
UPS, and GET complexes mutants, and mitochondrial fusion and fission
mutants), suggesting that CL is required for mitochondrial protein import and
maintenance of morphology.
How does the loss of CL affect mitochondrial protein import? A
previous report from the Greenberg lab indicated that the loss of CL leads to
decreased protein import and membrane potential at non-permissive
temperature (Jiang et al., 2000). In the current study, we observed that
several genes from the TIM complex genetically interact with cells lacking CL
(Table 2.5). Loss of CL affects interaction between the TIM and PAM
complexes (Tamura et al., 2009). In addition to this, it affects the
electrophoretic mobility of the TIM22 complex, required for insertion of
metabolic carrier proteins in the inner mitochondrial membrane (Tamura et al.,
2009). It appears from these studies that mitochondrial protein import in crd1Δ
mutant cells might not only be affected by a decrease in membrane potential
but also by altered activity and assembly of these protein complexes.
Interestingly, we also showed that several genes from the TOM complex
genetically interact with crd1Δ and taz1Δ mutants, strongly indicating that CL
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shares functions with the outer membrane proteins required for protein import.
Consistent with this, we provide evidence that a detectable amount of CL is
present in the outer membrane and is required for assembly of the β barrel
protein in yeast as well as in mitochondria from lymphoblasts isolated from a
Barth patient (Gebert et al., 2009). Thus, CL is required for outer membrane
biogenesis. Taken together, the genetic interaction data suggest that CL is
required for the biogenesis of translocases of the inner and outer membrane.
What is the function of CL in the maintenance of mitochondrial
morphology? Mitochondrial morphological defect in cells lacking CL could be
due to decreased membrane potential or decreased mitochondrial import
(Stojanovski et al., 2006). Recent studies have shown that CL could have a
direct effect on mitochondrial morphology (Chapter 3) (DeVay et al., 2009;
Joshi et al., 2012; Rujiviphat et al., 2009). In the genetic screen with
mitochondrial morphology mutants, we have shown that the GET and UPS
complexes genetically interacted with the crd1Δ mutant, indicating that these
modifiers share cellular functions with CL. Our findings indicate that the GET
complex might be required for the regulation of CL levels, as the loss of GET
proteins such as Get1p and Get2p leads to decreased CL levels. In addition
to this, the crd1Δ mutant interacted with several other mitochondrial
morphology mutants, indicating that CL is required for the maintenance of
mitochondrial morphology.
The goal of the synthetic lethality screen performed in this study was to
identify functions of CL that might be physiological modifiers of BTHS. In the
current study, we showed that CL is required for mitochondrial protein import
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and maintenance of mitochondrial morphology. How could mitochondrial
protein import and mitochondrial morphology act as physiological modifiers of
BTHS? Import of proteins into the mitochondria is an intricate process that
requires the presence of target sequences in the proteins, targeting of protein
to the TOM complex present in the outer membrane, and the translocation of
proteins into the mitochondria. Errors in these events may lead to disease in
humans due to decreased mitochondrial proteins. As discussed previously,
DCMA syndrome is an illness caused by mutation in a protein (Tim14p)
required for import. Pyruvate dehydrogenase deficiency is a disease caused
by mutation in the targeting signal of one subunit of pyruvate dehydrogenase
enzyme (PDH). As a result, the mitochondrial import of PDH is defective. PDH
deficiency is the most common cause of lactic acidosis in infants and children.
Interestingly, BTHS patients exhibit lactic acidosis upon exercise (Sweeney et
al., 2008). Thus, it is possible that import of PDH is decreased in cells with
defective CL. Mutation in Hsp60, a mitochondrial matrix chaperone, causes
atypical

mitochondrial

disease

involving,

perturbation

of

oxidative

phosphorylation, β-oxidation, and pyruvate metabolism (Agsteribbe et al.,
1993; Briones et al., 1997). Consistent with this, we observed that cells
lacking CL appear to be defective in these metabolic pathways, as described
in Chapter 4. Thus, mitochondrial protein import is potentially a vital
physiological modifier that may lead to metabolic deficiencies in BTHS.
The functional state of mitochondria affects its morphology. Defects in
mitochondrial protein import, decreased ATP levels or increased ROS lead to
defective morphology (Stojanovski et al., 2006). The genetic screen discussed
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in the current study identified several players that might act as physiological
modifiers of CL in BTHS, including the UPS and GET complexes. GET
complex mutants, which have defective mitochondrial morphology, regulate
CL levels. In addition, subsequent studies following up on the synthetic lethal
data with fusion mutants (discussed further in chapter 3) indicate that CL is
required for mitochondrial fusion (Joshi et al., 2012). Therefore, mitochondrial
fusion could be a physiological modifier of BTHS. The role of mitochondrial
fusion as a physiological modifier of BTHS is discussed in Chapter 3. Thus,
genes that interact with CRD1 may identify functions that affect the BTHS
phenotype. An increased understanding of the role of CL and its regulation
could identify potential avenues for new treatments of BTHS.
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CHAPTER 3

CARDIOLIPIN AND MITOCHONDRIAL PHOSPHATIDYLETHANOLAMINE
HAVE OVERLAPPING FUNCTIONS IN MITOCHONDRIAL FUSION IN
SACCHAROMYCES CEREVISIAE

The work in this chapter is published in the Journal of Biological Chemistry
2012 May 18;287(21):17589-97. I thank Morgan N. Thompson for
constructing the crd1Δpsd1Δ conditional mutant, Naomi Fei for assistance
with tetrad dissection and microscopy, and Dr. J. Michael McCaffery,
Integrated Imaging Centre (Johns Hopkins University), for providing EM
images.
INTRODUCTION
Mitochondria exist as dynamic, double membrane-bound organelles.
Mitochondrial membranes are enriched in phospholipids and proteins that are
required for mitochondrial biogenesis and for maintenance of mitochondrial
morphology and the tubular network (Gohil and Greenberg, 2009). CL and PE
are non-bilayer forming phospholipids in the mitochondrial membranes (Ardail
et al., 1990; Gonzalvez and Gottlieb, 2007) that play an essential role in
mitochondrial function. Although cells lacking CL or mitochondrial PE are
viable, the loss of both phospholipids is lethal, suggesting that these lipids
have overlapping functions that are essential (Gohil et al., 2005). Several
recent studies have implicated the involvement of CL and mitochondrial PE in
the maintenance of mitochondrial morphology (Kuroda et al., 2011a; Osman
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et al., 2009a; Tamura et al., 2009). CL and PE are fusogenic phospholipids
that form hexagonal phases in the presence of divalent cations, which confer
negative curvature to the mitochondrial membrane (Rand and Sengupta,
1972; van den Brink-van der Laan et al., 2004). In the current study, we
investigated the role of CL and PE in mitochondrial fusion. Highly conserved
protein machinery strictly regulates the process of mitochondrial fusion, and
recent studies suggest that phospholipids also play a vital role in this process.
Mitochondrial fusion in the yeast Saccharomyces cerevisiae primarily requires
three proteins. These include the outer membrane GTPase, Fzo1p (Mfn1 and
Mfn2 in mammals) (Hermann et al., 1998; Rapaport et al., 1998), the inner
membrane GTPase, Mgm1p (Opa1 in mammals) (Wong et al., 2000; Wong et
al., 2003), and the outer membrane protein Ugo1p, which links the two
GTPases to form a functional complex (Hoppins et al., 2009; Sesaki and
Jensen, 2001; Sesaki and Jensen, 2004). In S. cerevisiae, Mgm1p exists as
long (l-Mgm1p) and short isoforms (s-Mgm1p), both of which are required for
mitochondrial fusion (Herlan et al., 2003; Zick et al., 2009). In vitro studies
demonstrated that CL stimulates the GTPase activity of the s-Mgm1p (DeVay
et al., 2009; Rujiviphat et al., 2009). Moreover, it was shown in vitro that sMgm1p and l-Mgm1p assemble in a CL dependent manner (DeVay et al.,
2009). We hypothesized that the mitochondrial phospholipids CL and PE have
overlapping functions in mitochondrial fusion in vivo. Consistent with this
hypothesis, we demonstrate that cells lacking both CL and mitochondrial PE
have reduced levels of both Mgm1p isoforms and exhibit excessive
fragmentation of mitochondria and defects in mitochondrial fusion.
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MATERIAL AND METHODS

Yeast strains, plasmids and growth media:
The S. cerevisiae strains used in this study, listed in Table 3.1, are isogenic to
BY4741 and BY4742. The single mutants were obtained from the MATa yeast
deletion collection obtained from Dr. John Lopes. Double and triple mutants
used in this study were obtained by tetrad dissection. Synthetic complete
media contained standard concentration of amino acids, all the essential
components of DIFCO vitamin-free yeast nitrogen base, 0.2% ammonium
sulphate and glucose (2%). Synthetic dropout media contained all of the
aforementioned ingredients except the amino acid used as a selectable
marker. Complex media contained yeast extract (1%), peptone (2%), with
glucose (2%) (YPD) or galactose (2%) (YP-galactose) as carbon source. All
the plasmids were amplified and extracted using standard protocols. The
plasmids were transformed into yeast strains using a one-step transformation
protocol (Chen et al., 1992). The v5 epitope-tagged CRD1 gene was cloned
into the pCM189 plasmid (ATCC), in which, the TETOFF promoter regulates
the expression of cloned gene, using the BamHI and NotI restriction sites. The
existing URA3 marker of the plasmid was replaced by HIS3 using EcoRV and
ClaI restriction sites. Bacterial transformations were performed using damE.coli to avoid Dam methylase sensitivity to the ClaI restriction enzyme.

Fluorescence microscopy:
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Fluorescence

microscopy

was

performed

using

an

Olympus

BX41

epifluorescence microscope. Images were acquired using an Olympus QColor3 digitally charge-coupled device camera operated by QCapture2
software. All pictures were taken at 1,000 X. To stain mitochondrial DNA,
yeast cells were cultured to the mid-log phase, fixed in 70% ethanol at room
temperature for 30 min, washed two times with distilled water, and stained
with 1 µg/ml DAPI (Sigma) for 5 min. Mitochondria were visualized by
transforming the cells with either plasmid pYX142 or pYX122 expressing GFP
fused to the mitochondrial presequence, pre Su9 (Westermann and Neupert,
2000) (provided by Dr. Benedikt Westermann) or pYX142-mtRFP expressing
mitochondria targeted RFP (provided by Dr. Janet Shaw). Cells were
harvested in the appropriate medium and viewed under fluorescence
microscopy.

Electron microscopy:
Cells were grown in 100 ml YPD to an A550 of 0.5. After harvesting, cells were
prepared for EM using the osmium thiocarbohydrazide osmium fixation
method (Willingham and Rutherford, 1984).

In vivo fusion assay:
The mitochondrial in vivo fusion assay was performed as described (Nunnari
et al., 1997; Wong et al., 2003). MATα cells of WT, crd1Δ, and psd1Δ, were
transformed with pYX122-mtGFP and MATa cells were transformed with
pYX142-mtRFP. MATa cells of the conditional mutant crd1Δpsd1Δ were
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transformed with pYX142-mtRFP, and MATα cells with pYX142-mtGFP.
MATa cells of the conditional mutant crd1Δpsd1Δfis1Δ were transformed with
pYX142-mtGFP,

and

MATα

with

pYX142-mtRFP.

MATα

cells

of

crd1psd1dnm1Δ were transformed with pYX142-mtGFP and MATa with
pYX142-mtRFP. Cells were grown in 5 ml selective media to an A550 of 0.5.
After centrifugation, cells of opposite mating type were mixed and spotted on
an YPD plate. After 3.5 hours of incubation at 30°C, cells were observed for
mitochondrial fusion. The images were merged and analyzed using Image J
software.

Extraction, separation and analysis of yeast total phospholipids:
Yeast cells were grown in the presence of
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Pi (10 µCi/ml) in the indicated

growth conditions. Total phospholipids were extracted and analyzed by TLC
as described (Vaden et al., 2005). The developed chromatograms were
analyzed by phosphorimaging and the phospholipids were quantified using
Image Quant software.

Flow cytometry:
Mitochondrial membrane potential was measured using whole cells as
described (Ludovico et al., 2001). Cells were grown in YP-galactose media to
the mid-logarithmic phase. Actively growing cells (5x104 cells) were incubated
at 30°C with the dye tetramethyl rhodamine methyl ester (TMRM) (50nM) for
30 mins. To induce a decrease in membrane potential, control cells were
treated with sodium azide (20 mM). Fluorescence was measured using a flow
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cytometer. The results were analyzed using WinMDI2.9 software.

SDS-PAGE and Western blot analysis:
Proteins were extracted from cells grown to an A550 of 0.5, separated by 8%
SDS-PAGE, transferred to PVDF membrane and analyzed using primary
antibodies to Fzo1p (1: 1000), Ugo1p (1:1000), Mgm1p (1:500) (provided by
Dr. Jodi Nunnari) and α-tubulin (1:1000) (Santa Cruz Biotechnology). Proteins
were visualized using appropriate secondary antibody conjugated with
horseradish peroxidase (1:3000) followed by detection using the ECL
chemiluminescence system (GE Healthcare).
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Table 3.1: Strains used in this study.
Strains
BY4741
BY4742
VGY1
crd1Δ
psd1Δ
psd1Δ
dnm1Δ
fis1Δ
crd1Δpsd1Δ
crd1Δpsd1Δ
crd1Δpsd1Δ
fis1Δ
crd1Δpsd1Δ
fis1Δ
crd1Δpsd1Δ
dnm1Δ
crd1Δpsd1Δ
dnm1Δ

Genotype
MATa, his 301, leu 200, met 1500, ura 300
MATα , his 301, leu 200, lys 200, ura 300
MATα, his 301, leu 200, lys 200, ura 300,
crd1Δ::URA3
MATa, his 301, leu 200, met 1500, ura 300,
crd1Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
psd1Δ::KanMX4
MATα, his 301, leu 200, lys 200, ura 300,
psd1Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
dnm1Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
fis1Δ::KanMX4
MATα, his 301, leu 200, lys 200, ura 300,
crd1Δ::URA3, psd1Δ::KanMX4, pCM189-CRD1
MATa, his 301, leu 200, lys 200, met 1500, ura 300,
crd1Δ::URA3, psd1Δ::KanMX4, pCM189-CRD1
MATa, his 301, leu 200, lys 200, ura 300,
crd1Δ::URA3,
psd1Δ::KanMX4,
fis1Δ::KanMX4,
pCM189-CRD1
MATα, his 301, leu 200, lys 200, ura 300,
crd1Δ::URA3,
psd1Δ::KanMX4,
fis1Δ::KanMX4,
pCM189-CRD1
MATa, his 301, leu 200, ura 300, crd1Δ::URA3,
psd1Δ::KanMX4, dnm1Δ::KanMX4, pCM189-CRD1
MATα, his 301, leu 200, lys 200, met 1500, ura 300,
crd1Δ::URA3, psd1Δ::KanMX4, dnm1Δ::KanMX4,
pCM189-CRD1

Reference
Invitrogen
Invitrogen
Gohil et
al., 2005
Invitrogen
Invitrogen
This study
Invitrogen
Invitrogen
This study
This study
This study
This study

This study
This study
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RESULTS

Maintenance of a mitochondrial network and mitochondrial fusion is
defective in the absence of CL and mitochondrial PE
Previous studies have shown that loss of CL (crd1Δ) is lethal in combination
with loss of mitochondrial PE (psd1Δ), but not cytosolic PE (psd2Δ) (Gohil et
al., 2005). To gain insight into the overlapping roles of these mitochondrial
lipids, we constructed a conditional mutant, crd1Δpsd1Δ, in which CRD1 is
expressed from a plasmid under the control of the TETOFF promoter. This
mutant lacks mitochondrial PE and CL in the presence of tetracycline, but
contains CL in the absence of tetracycline. We used this conditional mutant as
a tool to identify functions of these phospholipids in mitochondrial morphology
and mitochondrial fusion. The conditional double mutant grew normally on
YPD. The addition of tetracycline (200 µg/ml), which shut off CRD1
expression, inhibited growth of the double mutant but did not affect growth of
WT, crd1Δ, or psd1Δ cells (Figure 3.1A). To determine if tetracycline did
indeed regulate CRD1 expression, we measured the levels of CL in
crd1Δpsd1Δ cells. In psd1Δ, CL was synthesized, although levels were
reduced compared to those of WT, consistent with previous studies (Gohil et
al., 2005). In crd1Δpsd1Δ grown in the absence of tetracycline, CL levels were
40% of those of psd1Δ, indicating that CL levels from plasmid CRD1 are less
than CL levels obtained from genomic CRD1. In the presence of tetracycline,
CL was greatly diminished to only 14% of the levels in psd1Δ, indicating that
expression from the TETOFF promoter was greatly (but not completely)
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repressed. Tetracycline itself did not affect CL levels in cells lacking the
plasmid, which were similar in psd1Δ cells grown in the presence and
absence of the drug (Figure 3.1B).
To determine if CL and mitochondrial PE play a role in the
maintenance of mitochondrial morphology, we compared the mitochondrial
network in WT, crd1Δ, psd1Δ, and crd1Δpsd1Δ cells transformed with
plasmids expressing mitochondria targeted GFP (mtGFP) (Westermann and
Neupert, 2000) (Figure 3.2A). At least 500 cells of each strain were observed
for each biological replicate (Figure 3.2B). Cells exhibited a normal tubular
mitochondrial network in crd1Δ, consistent with earlier findings (Chen et al.,
2010b), indicating that the lack of CL by itself does not affect the
mitochondrial network. The lack of mitochondrial PE had a small but
significant effect on the mitochondrial network, as ~23% of psd1Δ cells
exhibited fragmented mitochondria. Unlike the WT-like tubular mitochondrial
network, the majority of psd1Δ cells had short tubular mitochondria consistent
with a mitochondrial morphology defect in these cells. The morphology of
crd1Δpsd1Δ cells grown in the absence of tetracycline was similar to that of
psd1Δ cells. However, the addition of tetracycline severely affected the
mitochondrial network, leading to excessive mitochondrial fragmentation
similar to that observed in fusion mutants (Figure 3.2A, 3.2B). These findings
suggested that loss of both CL and mitochondrial PE leads to a defect in
mitochondrial fusion. Tetracycline by itself did not affect the mitochondrial
network in WT, crd1Δ and psd1Δ cells (data not shown). To determine if the
increase in mitochondrial fragmentation correlated with the loss of CL, a time
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course experiment was performed in which crd1Δpsd1Δ cells were grown in
YPD containing

32

Pi, in the presence or absence of tetracycline. Total

phospholipids and mitochondrial morphology were examined at 5, 8 and 11
hrs. Total CL decreased by ~11%, ~31%, and ~55% while the percentage of
mitochondrial fragmentation increased during this time to ~20%, ~45% and
~96% at 5, 8 and 11 hrs, respectively (Figure 3.2C, 3.2D). These findings
indicate that the increase in mitochondrial fragmentation corresponded with a
decrease in CL in the crd1Δpsd1Δ cells.
Electron microscopic examination of the mutants revealed that crd1Δ
mitochondria were somewhat smaller than those of WT, but relatively
unremarkable (data not shown). Mitochondria in psd1Δ cells and in
crd1Δpsd1Δ cells grown in the absence of tetracycline also appeared smaller
than WT. This phenotype was even more striking in crd1Δpsd1Δ cells grown
in the presence of tetracycline. Thus, the loss of both CL and mitochondrial
PE led to highly fragmented mitochondria, consistent with defective fusion
(Figure 3.2F). To determine the role of CL and mitochondrial PE in
mitochondrial fusion, we performed an in vivo fusion assay (Nunnari et al.,
1997; Wong et al., 2003) as described in “Materials and methods.” In this
assay, we examined the mitochondrial fusion events in zygotes acquired by
mating haploids of opposite mating types of WT, crd1Δ, psd1Δ, and
crd1Δpsd1Δ cells transformed with either mtGFP or mitochondria tagged RFP
(mtRFP). As expected, crd1Δ cells exhibited complete mixing of mitochondrial
content, indicating that the lack of CL alone does not affect mitochondrial
fusion (Figure 3.3A). Fusion occurred but was decreased in psd1Δ cells,
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A

B

Figure 3.1: Tetracycline-dependent growth of the conditional mutant
crd1Δpsd1Δ. A) 10-fold serial dilutions of cell suspensions were spotted on
YPD plates supplemented with 200 µg/ml tetracycline (Tet) where indicated
and incubated at 30°C. B) Cells were grown in YPD for 12 h in the presence
or absence of tetracycline. Steady state labeling, phospholipid extraction, one
dimensional TLC, phosphorimaging, and quantification were carried out as
described under “Materials and methods.” CL levels are quantified as percent
of total phospholipids. Mean values ± S.D. of two independent experiments
are

shown.

PC,

phosphatidylcholine;

PI,

phosphatidylinositol;

phosphatidylserine; PG, phosphatidylglycerol; PA, phosphatidic acid.

PS,
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Figure 3.2: Mitochondrial fragmentation observed in crd1Δpsd1ΔCRD1
cells. A) Mitochondria were visualized using mtGFP. Cells were grown at
30°C to log phase in synthetic leucine deficient medium with or without 200
µg/ml tetracycline (Tet) and examined by fluorescence microscopy. Bars,1
µm. B) Quantitation of cells containing fragmented mitochondria. Values are
mean ± S.E. (n=3). At least 500 cells were visualized in each experiment. C–
F, the crd1Δpsd1ΔCRD1 mutant cells were grown at 30° C in the presence or
absence of 200 µg/ml tetracycline and harvested at the indicated times. C) CL
levels were analyzed by one-dimensional TLC as described under “Materials
and methods” and relative levels of CL are indicated. Values are mean ± S.E.
(n=3). D) Cells containing fragmented and tubular mitochondrial morphology
were quantified. Values are mean ± S.E. (n =3). E) Total cell proteins were
extracted and analyzed by SDS-PAGE followed by Western blot. F) Aliquots
of crd1Δpsd1Δcells were fixed as described under “Materials and methods”
and thin sections were examined by electron microscopy. Labels m and V
indicate mitochondria and vacuole (white area), respectively. Bars, 500 nm.
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suggesting that the lack of PE causes somewhat reduced fusion even when
CL is present. As expected, the fusion phenotype of crd1Δpsd1Δ cells grown
in the absence of tetracycline was similar to that of psd1Δ cells. However, in
the presence of tetracycline, a complete block of mitochondrial fusion was
observed in all the crd1Δpsd1Δ zygotes examined, consistent with the
defective mitochondrial network observed in the absence of both CL and
mitochondrial PE (Figure 3.3A). These results indicate that when both CL and
mitochondrial PE are deficient, mitochondrial fusion does not occur.

Loss of mitochondrial DNA and reduced mitochondrial membrane
potential in cells lacking CL and mitochondrial PE
Several studies have reported that cells defective in mitochondrial fusion lose
mitochondrial DNA (mtDNA) (Chen et al., 2010a; Guan et al., 1993; Herlan et
al., 2003; Hermann et al., 1998; Nunnari et al., 1997). Therefore, we
hypothesized that crd1Δpsd1Δ cells would exhibit mtDNA loss. To address
this possibility, WT, crd1Δ, psd1Δ, and crd1Δpsd1Δ cells were grown with or
without tetracycline to the mid-logarithmic growth phase at 30°C. Cells were
observed under the fluorescence microscope after DAPI staining for the
presence of mtDNA (Figure 3.4A). As expected, the majority of crd1Δpsd1Δ
cells (~80%) grown in the absence of tetracycline at the permissive
temperature of 30°C retained the mtDNA. This was consistent with our
previous study showing that crd1Δ cells retained mtDNA at 30°C but exhibited
mtDNA loss only at elevated temperatures (Zhong et al., 2004). However, in
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the presence of tetracycline, only ~20% of crd1Δpsd1Δ cells had mtDNA
(Figure 3.4B).
Mitochondrial fusion as determined by in vitro assay involves distinct
steps of outer and inner membrane fusion (Meeusen et al., 2004). In addition
to functional protein complexes, fusion of the outer membrane requires low
GTP levels and a proton gradient, while inner membrane fusion requires large
amounts of GTP and an inner membrane potential. It is therefore possible that
a decreased membrane potential led to the fusion defect in crd1Δpsd1Δ cells.
To test this possibility, we used a flow cytometry assay to measure
mitochondrial membrane potential (ΔΨm) in intact WT, crd1Δ, psd1Δ, and
crd1Δpsd1Δ cells grown with or without tetracycline (Ludovico et al., 2001) in
YP-galactose

rather

than

YP-glucose

to

ensure

actively

respiring

mitochondria. Cells were grown at 30°C to the mid-logarithmic growth phase
and then incubated with the voltage-dependent probe tetramethylrhodamine
methyl ester (TMRM) (50 nM) for 30 minutes. The accumulation of TMRM in
mitochondria is driven by the ΔΨm, which is determined by the difference in
yellow fluorescence and forward scatter in the form of fluorescence peaks
(Ludovico et al., 2001). Values were calculated relative to the control, i.e.,
crd1Δpsd1Δ cells grown in the absence of tetracycline. As seen in Figure
3.4C, crd1Δpsd1Δ cells in the presence of tetracycline exhibited a decrease in
membrane potential similar to that observed in these cells in the presence of
sodium azide, a cytochrome c oxidase inhibitor that reduces the ΔΨm
(Ludovico et al., 2001). These observations were consistent with a reduced
membrane potential in cells lacking both CL and mitochondrial PE. It was
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recently demonstrated that mitochondrial fusion in mammalian cells requires
high ΔΨm levels and is prevented by depolarization (Mitra et al., 2009). Thus,
the observed decrease of ΔΨm could be one explanation for the fusion
defects in the crd1Δpsd1Δ mutant cells.

Deletion of DNM1 in crd1Δ psd1Δ cells restores normal mitochondrial
tubular network
We wished to determine if the mitochondrial fragmentation observed in
crd1Δpsd1Δ cells could be explained by increased fission rather than
decreased fusion. Fusion and fission regulate mitochondrial morphology in an
antagonistic manner (Hoppins et al., 2007). Previous studies have shown that
three major proteins regulate mitochondrial fission, Dnm1p (Bleazard et al.,
1999; Mozdy et al., 2000; Sesaki and Jensen, 1999), Fis1p (Mozdy et al.,
2000), and Mdv1p (Tieu and Nunnari, 2000; Tieu et al., 2002). Abolishing
mitochondrial fission by deletion of any of these genes leads to net-like
mitochondria. In contrast, eliminating fusion by deletion of MGM1, FZO1 or
UGO1 leads to fragmentation, which can be restored to normal tubular
morphology by deletion of the fission gene DNM1 (Sesaki and Jensen, 1999;
Wong et al., 2003). If mitochondrial fragmentation in crd1Δpsd1Δ cells results
from a defect in fusion and not increased fission, then disruption of
mitochondrial fission would restore mitochondria to the normal tubular
morphology. Therefore, we examined if the fragmented mitochondrial
morphology of crd1Δpsd1Δ cells could be rescued to normal tubular
mitochondrial morphology by deletion of the fission gene DNM1. To do so, we

68

Figure 3.3: crd1Δpsd1Δ cells exhibit defective mitochondrial fusion. (A)
Cells of opposing mating type were transformed with either mtGFP or mtRFP.
Mitochondrial fusion was examined by observing merged images of mtGFP
and mtRFP in WT (a-d), crd1Δ (e-h), psd1Δ (i-l) and crd1Δpsd1Δ cells grown
without (m-p) or with (q-t) tetracycline. Bars, 1 µm. (B) Total cellular proteins
were analyzed by SDS-PAGE followed by Western blot. Steady state levels of
Mgm1p, Fzo1p and Ugo1p were measured. α-tubulin was used as a loading
control. (C) Quantitation of fusion proteins. Values are mean ± SE (n = 3).

69

Figure 3.4: crd1Δpsd1Δ cells exhibit loss of mitochondrial DNA and
reduced membrane potential. (A) Cells were grown in YP-gal to log phase
at 30°C with or without 200 µg/ml tetracycline (Tet) and stained with DAPI.
Bars, 1µm. (B) Quantitation of cells containing mtDNA. Values are mean ± SE
(n = 3). At least 500 cells were visualized in each experiment. (C) Dissipation
of

the

mitochondrial

membrane

potential

demonstrated

as

TMRM

fluorescence (%) in crd1Δpsd1Δ cells grown to log phase in YP-gal with or
without tetracycline and stained with TMRM. Cells were also treated with
sodium azide as control.

70

constructed a crd1Δpsd1Δdnm1Δ conditional mutant containing the plasmid
with the TETOFF regulated CRD1 expression plasmid, as well as a plasmid
expressing mtGFP (Figure 3.5A). In the absence of tetracycline, when CRD1
is expressed, the crd1Δpsd1Δdnm1Δ cells would be expected to exhibit netlike mitochondria characteristic of a fission defect. However, in the presence
of tetracycline, the cells would be predicted to lack both fission and fusion
and, hence, would exhibit WT tubular mitochondrial morphology.
As seen in Figure 3.5B, ~76% of crd1Δpsd1Δdnm1Δ cells grown in the
absence of tetracycline exhibited net-like mitochondria, the predicted
phenotype. The remaining cells (~18%) exhibited tubular mitochondria, most
likely because fusion was decreased in these cells due to the low level of
expression of CRD1 (Figure 1). In the presence of tetracycline, only ~32% of
cells exhibited net-like mitochondria while the majority (~45%) exhibited
tubular mitochondria, as predicted. These findings suggest that both fission
and fusion were defective in these cells and that the fragmented mitochondrial
morphology in crd1Δpsd1Δ cells was rescued by deletion of the fission gene
DNM1 (Figure 3.5A, 3.5B). Tetracycline itself did not affect the mitochondrial
morphology in dnm1Δ (data not shown). Interestingly, a significant number of
crd1Δpsd1Δdnm1Δ cells (~22%) grown in the presence of tetracycline, had
fragmented mitochondria, as the network exhibited the appearance of a string
of beads (data not shown). This morphology suggested the presence of a
persistent fusion defect in the absence of CL and mitochondrial PE.
To further investigate the block in fusion, we performed an in vivo
mitochondrial fusion experiment by mating crd1Δpsd1Δdnm1Δ cells of
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opposite mating types, in which one mating type contained mtGFP and the
other mating type contained mtRFP. We observed decreased fusion in cells
grown without tetracycline, and a complete block in mitochondrial fusion in
cells grown with tetracycline (Figure 3.5C). Cells grown without tetracycline
that exhibited net-like structures had no defect in mitochondrial fusion (Figure
3.5C). Cells grown in the presence of tetracycline displayed a complete block
of mitochondrial fusion. Similar observations were made in the conditional
mutant crd1Δpsd1Δfis1Δ (data not shown). These experiments suggest that
crd1Δpsd1Δdnm1Δ cells exhibited a fusion defect due to loss of CRD1 and
PSD1.

Taken

together,

these

studies

indicate

that

mitochondrial

fragmentation observed in crd1Δpsd1Δ cells is a result of defective fusion and
not due to increased fission.
To determine if deletion of the fission gene FIS1 or DNM1 could
rescue the lethality of the double mutant, we crossed crd1Δdnm1Δ and
crd1Δfis1Δ with psd1Δ and carried out meiotic tetrad analysis to identify viable
triple mutants. However, triple mutants were not detected in 72 tetrads of the
diploid crd1Δfis1ΔPSD1/CRD1FIS1psd1Δ or 75 tetrads of the diploid
crd1Δdnm1ΔPSD1/CRD1DNM1psd1Δ. Therefore, while CL and mitochondrial
PE have overlapping functions in mitochondrial fusion, rescue of the fusion
defect could not rescue the synthetic lethality.
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Figure 3.5: crd1Δpsd1Δdnm1Δ cells are defective in mitochondrial
fusion. (A) Mitochondria were visualized in the crd1Δpsd1Δdnm1Δ mutant
using mtGFP. Cells were grown at 30°C to log phase in synthetic deficient
glucose medium with 200 µg/ml tetracycline (Tet) where indicated and
examined by fluorescence microscopy. Bars, 1µm. (B) Cells containing
tubular, fragmented and net-like mitochondria were quantified. Values are
mean ± SE (n = 3). At least 100 cells were visualized in each experiment. (C)
crd1Δpsd1Δdnm1Δ cells of opposing mating type were transformed with either
mtGFP or mtRFP. Mitochondrial fusion was examined by observing merged
images of mtGFP and mtRFP in zygotes of crd1Δpsd1Δdnm1Δ grown without
(a-d) or with (e-h) tetracycline. Bars, 1µm.
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Reduced steady state levels of l-Mgm1 and s-Mgm1 isoforms in cells
lacking CL and mitochondrial PE
The current study suggests that one common function of CL and PE is
mitochondrial fusion. It has been reported that the lack of CL destabilizes the
anchoring, assembly, and GTPase activity of fusion protein Mgm1p in vitro
(Ban et al., 2010; DeVay et al., 2009; Rujiviphat et al., 2009). To test if
mitochondrial PE compensates for the loss of CL and stabilizes the fusion
proteins in vivo, we determined the steady state levels of fusion proteins
Fzo1p, Ugo1p, l-Mgm1p and s-Mgm1p in WT, crd1Δ, psd1Δ, and crd1Δpsd1Δ
cells. The crd1Δpsd1Δ cells exhibited significantly diminished levels of lMgm1p and s-Mgm1p (Figure 3.3B, 3.3C). Fzo1p levels were slightly
decreased and Ugo1p was not affected (Figure 3.3B, 3.3C). To determine if
the loss of Mgm1p isoforms correlated with the loss CL in crd1Δpsd1Δ, cells
were grown in the presence or absence of tetracycline, proteins were
extracted from cells harvested at 5, 8 and 11 hrs, and the levels of Mgm1p
isoforms were determined by Western blot (Figure 3.2E). The isoform levels
were severely diminished at 11 hrs, which correlated with increased
mitochondrial fragmentation as seen in Figure 3.2C. These data indicate that
the defect in mitochondrial fusion in crd1Δpsd1Δ can be attributed at least in
part to the reduced levels of s-Mgm1p and the 1-Mgm1p.
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DISCUSSION

In this study, we demonstrate that crd1Δpsd1Δ cells lacking both CL and
mitochondrial PE have fragmented mitochondria due to a defect in
mitochondrial fusion. In addition to this defect, we show that crd1Δpsd1Δ cells
exhibit loss of mtDNA, decreased membrane potential, and reduced steady
state levels of short and long isoforms of Mgm1p, a mitochondrial inner
membrane protein essential for fusion. The fragmented mitochondrial
morphology along with the fusion defect observed in crd1Δpsd1Δ cells were
rescued by deletion of the fission genes DNM1 or FIS1. These data indicate
that CL and mitochondrial PE are required for mitochondrial fusion in vivo.
Our previous studies have shown a synthetic lethal interaction between
crd1Δ and psd1Δ mutant cells, suggesting essential overlapping roles of CL
and mitochondrial PE (Gohil et al., 2005). PE synthesized by the nonmitochondrial pathway (Psd2p catalyzed PE synthesis in Golgi/vacuole)
(Trotter et al., 1993; Trotter et al., 1995; Trotter and Voelker, 1995) did not
rescue this lethality. Externally synthesized PE is inefficiently transported to
the inner mitochondrial membrane, as reduced levels of PE were observed in
the inner mitochondrial membrane of psd1Δ mutant cells (Burgermeister et al.,
2004). Taken together, these studies suggested that PE synthesized in the
mitochondrial inner membrane has functions that cannot be compensated by
externally synthesized PE. In the current study, we demonstrate that the loss
of

mitochondrial

phospholipids

CL

and

PE

leads

to

mitochondrial

fragmentation (Fig. 2A, 2B, and 2F) and defective mitochondrial fusion (Fig.
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3A). Although mitochondrial fusion is an overlapping function of CL and PE,
the lack of mitochondrial fusion is probably not the cause of lethality observed
in crd1Δpsd1Δ cells, as lethality was not rescued by deletion of the fission
gene FIS1 or DNM1. Mitochondria are required not only for cellular
bioenergetics, but also for the synthesis of essential metabolites. In addition,
our previous studies have shown that CL is required for non-mitochondrial
functions, including vacuolar function, the high osmolarity glycerol (Schuller et
al., 1994) pathway, and cell wall synthesis (Chen et al., 2008b; Zhong et al.,
2007; Zhou et al., 2009). Thus, it is possible that lethality in cells lacking CL
and PE could be caused by deficiencies in both mitochondrial and nonmitochondrial functions. The identification of suppressors of crd1Δpsd1Δ
synthetic lethality will very likely identify the essential cellular functions shared
by these phospholipids. These studies are currently in progress.
How do CL and mitochondrial PE affect mitochondrial fusion? Nonbilayer lipids are known to affect the function and stability of many
mitochondrial membrane proteins (Schlame and Ren, 2009). Recent studies
have proposed that scaffolding proteins such as prohibitin recruit membrane
proteins to CL and PE rich regions, forming protein rich lipid domains (Osman
et al., 2011). The lack of CL and mitochondrial PE might influence the
distribution of these domains, which in turn would affect several mitochondrial
processes, including mitochondrial fusion. Although early studies suggested
that the non-bilayer forming phospholipids CL and PE play an important role
in mitochondrial fusion, very little was known about the mechanism by which
this could occur (Cullis and de Kruijff, 1979; Furt and Moreau, 2009; van den
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Brink-van der Laan et al., 2004). In this study, we show that the lack of CL
and mitochondrial PE leads to reduced steady state levels of both large and
small isoforms of Mgm1p (Fig. 2E, 3B), which are required for fusion. Recent
studies have shown that l-Mgm1p acts as an anchor in the inner membrane
(Zick et al., 2009). Both CL and PE are synthesized and predominantly
localized in the inner mitochondrial membrane, and the loss of both CL and
mitochondrial PE might affect the stability of this isoform, leading to its
degradation. The formation of s-Mgm1p requires functional mitochondrial
protein import machinery, membrane potential and adequate ATP levels, all of
which are defective in cells lacking CL (Claypool et al., 2008; Duvezin-Caubet
et al., 2006; Gebert et al., 2009; Herlan et al., 2004; Jiang et al., 2000). This is
a first report describing the overlapping roles of CL and mitochondrial PE in
fusion in vivo, and suggests a mechanistic role for these phospholipids in
regulating mitochondrial structure and function.
How is the role of CL and PE in mitochondrial fusion relevant to human
disease? The role of mitochondrial phospholipids in fusion is relevant to
studies that implicate function of mitochondrial fusion in cardiac function (Dorn
et al., 2011). Fragmented mitochondria are associated with the loss of Opa1
(the human homolog of Mgm1p) in mitochondrial myopathies involving cardiac
and skeletal muscle (Duvezin-Caubet et al., 2006) and in ischemic
cardiomyopathy (Chen et al., 2009). Overexpression of the fusion proteins
Mfn1/2 (human homolog of Fzo1p) prevents cardiac cell death from ischemia
(Ong et al., 2010). Elucidating the role of CL and PE in mitochondrial fusion
may also shed light on defects observed in lymphoblast mitochondria from
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patients with Barth syndrome (BTHS), a severe genetic disorder characterized
by dilated cardiomyopathy and skeletal myopathy (Barth et al., 1996; Bolhuis
et al., 1991). BTHS is caused by mutation in the CL remodeling enzyme
tafazzin, resulting in decreased CL and altered fatty acid composition of major
mitochondrial phospholipids, including CL and PE (Xu et al., 2005). Defects in
mitochondrial fusion may account for the observed morphological variation in
BTHS mitochondria, including enlarged size, fragmentation, adhesion of
opposing membranes and deformed intercristae space observed in BTHS
lymphoblasts as well as in cardiac and skeletal muscle mitochondria of the
mouse model of BTHS (Acehan et al., 2011; Acehan et al., 2007). Identifying
the role of CL and PE in mitochondrial fusion may thus explain, in part, the
wide

variation

in

the

clinical

presentation

observed

in

BTHS.
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CHAPTER 4

PERTURBATION OF THE TCA CYCLE IN CELLS LACKING CARDIOLIPIN
CANNOT BE ALLEVIATED DUE TO DEFECTIVE MITOCHONDRIAL
RETROGRADE RESPONSE

INTRODUCTION

Cardiolipin (CL) is synthesized in the mitochondrial inner membrane and
interacts with various inner membrane protein complexes (Houtkooper and
Vaz, 2008; Pfeiffer et al., 2003). CL mutants exhibit deficiencies in
mitochondrial bioenergetics (Koshkin and Greenberg, 2000; Koshkin and
Greenberg, 2002), perturbation of mitochondrial protein import, decreased
membrane potential (Jiang et al., 2000), and defective assembly of
mitochondrial outer membrane complexes in both yeast and Barth syndrome
(BTHS) lymphoblasts (Gebert et al., 2009). Clearly, perturbation of CL
synthesis disrupts numerous important mitochondrial functions.
The mitochondrion is an essential organelle that plays a crucial role in
cellular bioenergetics, programmed cell death, and metabolism. The
tricarboxylic acid cycle (TCA) is the central metabolic pathway that occurs in
the mitochondrial matrix of eukaryotic cells. The TCA cycle is an amphibolic
pathway that is critical for oxidation of acetyl-CoA and for the production of the
reducing agent NADH, which is used by the respiratory complexes to
generate ATP. It is also important for biosynthetic processes, including amino
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acid and heme biosynthesis. TCA cycle enzymes are more important for cell
growth when non-fermentable carbon sources are metabolized. Nevertheless,
the first three steps of the TCA cycle leading to the synthesis of αketoglutarate are expressed at basal levels even during growth on glucose. αketoglutarate is a precursor for synthesis of glutamate, which is utilized for the
synthesis of glutamine, proline and arginine.
Yeast cells respond to the loss of mitochondrial DNA or to decreased
mitochondrial function resulting from perturbation of the TCA cycle by
signaling the nucleus to modulate the expression of genes required to
replenish key mitochondrial metabolites (Epstein et al., 2001). In particular,
the expression of genes required for glutamate biosynthesis is upregulated by
activation of the mitochondrial retrograde (RTG) pathway (Gangloff et al.,
1990; Liu and Butow, 1999). Target genes that respond to RTG signaling
include CIT2, CIT1, ACO1, IDH1 and IDH2, which are required for glutamate
synthesis, and DLD3, a cytosolic D-lactate dehydrogenase (Chelstowska and
Butow, 1995; Liao and Butow, 1993; Liao et al., 1991; Liu and Butow, 1999).
Thus, the central role of the RTG pathway is to replenish TCA cycle
intermediates, such as α-ketoglutarate, which is a precursor for glutamate
biosynthesis.
The RTG pathway is regulated by several positive (Rtg1p, Rtg2p,
Rtg3p, Grr1p) and negative (Mks1p, Bmh1p, Bmh2p, Lst8p) regulators that
control expression of the RTG target genes (Figure 4.1) (Liu and Butow,
2006). In response to decreased mitochondrial function, the RTG pathway is
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Figure 4.1: The positive (blue) and negative (red) regulators of the RTG
pathway. Based on the functional state of mitochondria, and availability of
glutamate, the positive and negative regulators of the RTG pathway modulate
expression of the target genes (Liu and Butow, 2006).
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activated by dephosphorylation and translocation of Rtg3p/Rtg1p into the
nucleus (Sekito et al., 2000). Rtg1p and Rtg3p are transcription factors that
bind to the promoter region (R box) of target genes such as CIT2 (Sekito et
al., 2000). Mks1p, a negative regulator of the RTG pathway, prevents the
translocation of Rtg3p/Rtg1p into the nucleus by promoting phosphorylation of
Rtg3p. It acts downstream of Rtg2p and upstream of Rtg1/3p (Dilova et al.,
2004). Thus, Rtg2p is required for dephosphorylation of Rtg3p and nuclear
translocation of Rtg1/3p (Liu et al., 2003). In addition, Rtg2p binds to the
promoter region of CIT2 and increases its expression under inducible
conditions (Pray-Grant et al., 2002). Bmh1p and Bmh2p (14-3-3 proteins) act
as negative regulators of the RTG pathway by preventing degradation of
Mks1p. These proteins are known to bind different phosphorylated proteins;
hence, they have diverse cellular functions, in addition to their role in the RTG
pathway (Gelperin et al., 1995; Kakiuchi et al., 2007).
In addition to the RTG pathway, other routes to replenish the TCA
cycle metabolites in yeast include β-oxidation and the glyoxylate cycle (Figure
4.2). These two metabolic pathways complement each other and replenish
vital metabolites such as acetyl CoA, succinate, and citrate. Acetyl CoA is a
central metabolite of carbon assimilation in eukaryotic cells. In addition to
synthesis of acetyl CoA from pyruvate by pyruvate dehydrogenase (PDH) in
the mitochondria, acetyl-CoA is imported into the mitochondria via two
pathways (Elgersma et al., 1995; van Roermund et al., 1999). One requires
CIT2, a peroxisomal citrate synthase that converts acetyl-CoA into the
glyoxylate cycle intermediates succinate and citrate. These metabolites are
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Figure 4.2: Metabolic pathways that replenish the TCA cycle. The
glyoxylate cycle and the β-oxidation pathway compensate the TCA cycle by
providing metabolic intermediates. The glyoxylate cycle provides citrate and
succinate while the β-oxidation pathway provides acetyl-CoA to the TCA
cycle. Glyoxylate cycle and glutamate biosynthesis genes that require Rtg1p,
Rtg2p, and Rtg3p for expression are underlined. Metabolite transporters are
in bold. Modified from Liu and Butow, 2006.
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imported into the mitochondria by carrier proteins. The second pathway
involves transport of acetyl-carnitine into the mitochondria via the carnitine
transporter Crc1p (van Roermund et al., 1999). Interestingly, some BTHS
patients have decreased levels of carnitine and accumulation of fat droplets
due to decreased transport of acetyl CoA into the mitochondria (Barth et al.,
1983). In the mitochondria, carnitine acetyl CoA transferase catalyzes the
release of acetyl units, which can be utilized subsequently in the TCA cycle.
Studies from the Greenberg lab have shown that: 1) CL mutants exhibit
decreased activity of the TCA cycle enzymes aconitase and succinate
dehydrogenase (Vinay Patil, unpublished); 2) CL mutants are synthetically
lethal with pyruvate dehydrogenase mutants, suggesting that acetyl CoA
synthesis is decreased in the mutants (Vaishnavi Raja, unpublished); and 3)
genes that play a role in acetate metabolism, uptake of acetyl CoA into the
mitochondria, and transporters of lactate and several amino acid are upregulated in the crd1Δ mutant (Vishal Gohil, unpublished). These findings
suggest that CL deficiency leads to perturbation of the TCA cycle. As
discussed above, a block in the TCA cycle leads to activation of the
mitochondrial RTG pathway by up regulation of CIT2 gene expression. In this
study, I report that CIT2 is not upregulated in cells lacking CL at elevated
temperature despite the mitochondrial dysfunction present in these cells. In
addition, I find that overexpression of RTG2 or supplementation of glutamate
rescues the growth defect of crd1Δ at elevated temperature. Based on these
findings, I hypothesize that CL deficiency leads to perturbation of the TCA
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cycle, which is not alleviated due to either defective or insufficient activation of
the RTG pathway.
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Materials and methods

Yeast strains and growth media:
The yeast strains used in this study are isogenic to BY4741 and BY4742
(Table 4.1). Complex medium (YPD) contained 1% yeast extract (US
Biological), 2% peptone (Fischer Scientific) and 2% glucose (Fischer
Scientific). Synthetic medium contained adenine (20.25 mg/liter), arginine (20
mg/liter), histidine (20 mg/liter), leucine (60 mg/liter), lysine (200 mg/liter),
methionine (20 mg/liter), threonine (300 mg/liter), tryptophan (20 mg/liter), and
uracil (20 mg/liter), vitamins, salts (essentially components of Difco Vitamin
Free Yeast Base without amino acids), and glucose (2%), acetate (2%) or
oleic acid (0.1%) as carbon source. Glutamate was added to a final
concentration of 0.05% when indicated. Sporulation medium contained
potassium acetate (1%), glucose (0.05%), and the essential amino acids.
Solid medium was prepared by adding 2% agar.

Construction of double mutants by tetrad dissection:
The CL mutant strain crd1Δ::URA3 MATα was crossed with mutants of the
opposite

mating

type

obtained

from

the

yeast

deletion

collection.

Heterozygous diploids were selected on synthetic media lacking methionine
and lysine, sporulated, and tetrads were dissected.
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Real time PCR:
Yeast cultures (10 ml) were grown to an A550 of 1.0 in YPD at 300C, cells were
harvested, and total RNA was isolated using the acid phenol method (Collart
and Oliviero, 2001). The RNA was then purified with an RNeasy Plus Mini Kit
(Qiagen). cDNAs were synthesized with a Transcriptor First Strand cDNA
Synthesis Kit (Roche). Real time PCR reactions were performed using a
quantitative PCR SYBR green mix (Stratagene). Duplicates for each sample
were included for each reaction. RNA levels of the gene of interest were
normalized to ACT1, which was used as an internal control.
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Table 4.1: Strains and plasmids used in this study
Strains
BY4742
VGY1

pYPGK18

Genotype
MATα, his 301, leu 200, lys 200, ura 300
MATα, his 301, leu 200, lys 200, ura 300,
crd1Δ::URA3
rho0 MATα , his 301, leu 200, lys 200, ura
300
rho0 MATα, his 301, leu 200, lys 200, ura
300, crd1Δ::URA3
MATa, his 301, leu 200, met 1500, ura 300,
rtg1Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
rtg2Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
rtg3Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
mks1Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
bmh1Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
bmh2Δ::KanMX4
MATα, his 301, leu 200, lys 200, ura 300,
crd1Δ::URA3, rtg1Δ::KanMX4
MATa, his 301, leu 200, lys 200, met 1500,
ura 300, crd1Δ::URA3, rtg2Δ::KanMX4
MATa, his 301, leu 200, lys 200, ura 300,
crd1Δ::URA3, rtg3Δ::KanMX4
MATα, his 301, leu 200, lys 200, ura 300,
crd1Δ::URA3, mks1Δ::KanMX4
MATa, his 301, leu 200, ura 300,
crd1Δ::URA3, bmh1Δ::KanMX4
MATα, his 301, leu 200, lys 200, met 1500,
ura 300, crd1Δ::URA3, bmh2Δ::KanMX4
2 µm, LEU2

pYPGK18RTG2

Derivative of pYPGK18, expresses RTG2
from PGK1 promoter

BY4742
VGY1
rtg1Δ
rtg2Δ
rtg3Δ
mks1Δ
bmh1Δ
bmh2Δ
crd1Δrtg1Δ
crd1Δrtg2Δ
crd1Δrtg3Δ
crd1Δmks1Δ
crd1Δbmh1Δ
crd1Δbmh2Δ

Reference
Invitrogen
Gohil et al.,
2005
Shuliang
Chen
Shuliang
Chen
Invitrogen
Invitrogen
Invitrogen
Invitrogen
Invitrogen
Invitrogen
This study
This study
This study
This study
This study
This study
Vaz et al.,
2003
Chen et al.,
2008
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Results

Overexpression of RTG2 alleviates the temperature sensitivity of cells
lacking CL
I utilized the genetic approach of suppressor analysis to identify functions of
CL that are deficient in CL mutants. To this end, I performed a suppressor
screen to isolate suppressors of the ts phenotype of taz1Δtom70Δ (Figure
2.2). The rationale for using the taz1Δtom70Δ mutant is that it exhibited a
more severe growth defect than crd1Δ, thus enabling more stringent
conditions for isolating suppressors. We obtained 45 putative suppressors
after screening 3119 transformants. RTG1 was a putative suppressor
identified in this screen. As the goal of the study was to identify cellular
functions of CL, I checked if RTG1 rescued the ts phenotype of crd1Δ.
Overexpression of RTG1 or RTG3 alone did not rescue the ts phenotype. In
contrast, I observed that overexpression of RTG2 rescued the ts phenotype of
the crd1Δ mutant (Figure 4.3). This suggested that the function of the RTG
pathway was deficient in crd1Δ at elevated temperature. Consistent with this,
deletion of RTG1, RTG2, or RTG3 in the crd1Δ mutant exacerbated the
growth phenotype at elevated temperature in synthetic media (Figure 4.4). As
discussed above, defects in the RTG pathway lead to glutamate auxotrophy,
as RTG proteins regulate the expression of genes required for glutamate
synthesis. We observed that supplementation of glutamate rescues the ts
phenotype of the crd1Δ mutant at elevated temperature (Figure 4.5), which is
consistent with the prediction that the RTG response in the CL mutant is
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Figure 4.3: Overexpression of RTG2 rescues temperature sensitivity of
crd1Δ. Cells were grown in leucine deficient synthetic medium overnight at
300C, diluted, plated on synthetic media lacking leucine and incubated at
300C and 390C for 3-5 days.
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Figure 4.4: RTG genes are required for growth of crd1Δ in synthetic
media without glutamate at elevated temperature. Cells were pre-cultured
overnight in YPD at 300C, plated on synthetic media with glucose lacking
glutamate and incubated at 370C for 3-5 days.
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Figure 4.5: Glutamate supplementation rescues the ts phenotype of
crd1Δ. Cells were pre-cultured overnight in YPD at 300C, washed and plated
onto synthetic media with or without 0.05% glutamate and incubated at 390C
for 3-5 days.
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insufficient to alleviate mitochondrial dysfunction at elevated temperature.

Cells lacking CL cannot induce expression of CIT2 at elevated
temperature.
Previous studies have shown that loss of mitochondrial DNA (Epstein et al.,
2001), decreased mitochondrial membrane potential (Miceli et al., 2011), and
decreased activities of TCA cycle enzymes such as succinate dehydrogenase
(Lin et al., 2011) lead to activation of the RTG pathway. Therefore, I expected
that in crd1Δ cells, which exhibit similar mitochondrial defects, the RTG
pathway would be activated and expression of the RTG target gene CIT2
would be increased. I found that CIT2 mRNA levels in crd1Δ cells, as
compared to WT, were upregulated ~4 fold relative to WT at 300C (Figure
4.6). However, to my surprise, CIT2 was not upregulated in crd1Δ at elevated
temperature, the condition in which it exhibits severe mitochondrial defects
(Figure 4.6). These results indicate that the RTG pathway is not activated at
elevated temperature in the crd1Δ mutant. As the RTG response is strain
specific, I checked if the defect in activation of the RTG pathway at elevated
temperature could be explained by a reduced RTG response in the BY4742
strain utilized in this study. To this end, I compared CIT2 mRNA levels in WT
rho0 and rho+ cells. As expected, CIT2 mRNA levels were ~5-fold upregulated
in WT rho0 compared to rho+ cells, indicating that the BY4742 strain does
exhibit an RTG response. Interestingly, crd1Δ rho0 cells exhibited a greater
increase in CIT2 mRNA levels than WT at 300C probably due to the
combinatorial effect of loss of mtDNA and decreased mitochondrial function
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Figure 4.6: Quantitative measurement of CIT2 mRNA levels. Total RNA
was extracted from cells grown to an A550 of 1.0 to 2.0 in YPD at 30°C and
39°C. mRNA levels of CIT2 were determined by real-time PCR. Expression
was normalized to the mRNA levels of the internal control ACT1. Values are
mean ± S.E from two independent experiments with technical duplicates.
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(Figure 4.6). Even though the retrograde pathway was activated in crd1Δ rho0
cells at 300C, these cells exhibited a growth defect in synthetic media that was
rescued by glutamate supplementation (Figure 4.7). Taken together, my
results suggest that crd1Δ cells can activate the RTG pathway at 300C but not
at the elevated temperature.

Deletion of negative regulator BMH2 rescues glutamate auxotrophy of
crd1Δ at elevated temperature
The loss of negative regulators of the RTG pathway leads to constitutive
expression of the target genes and rescue of glutamate auxotrophy (Dilova et
al., 2002). Therefore, I predicted that defective activation of the RTG pathway
would be rescued by deletion of the negative regulators, include MKS1,
BMH1, BMH2 and LST8. Among these, LST8 is an essential gene and the
null mutant is not viable. As the other genes are not essential, I deleted
MKS1, BMH1, and BMH2 in the crd1Δ mutant. I observed that deletion of
BHM2 but not MKS1 or BMH1 rescued the ts phenotype of the crd1Δ mutant
in synthetic media lacking glutamate (Figure 4.8). In contrast, deletion of
MKS1 exacerbated the crd1Δ mutant phenotype (Figure 4.8). A possible
explanation for this finding is that in the BY4742 background, Mks1p may not
be a negative regulator. Discrepancies regarding the role of MKS1 in the RTG
pathway have been reported (Dilova and Powers, 2006). While Mks1p was
shown to be a negative regulator in some studies (Dilova et al., 2002; Sekito
et al., 2002), Shamji et al., (2000) reported that RTG target gene expression
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Figure 4.7: crd1Δ rho0 exhibits glutamate auxotrophy at 300C. Cells were
pre-cultured overnight in YPD at 300C. WT rho0 and crd1Δ rho0 cells were
plated on synthetic media with or without 0.05% glutamate and incubated at
300C for 3-5 days.
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Figure 4.8: Deletion of BMH2 suppresses the ts phenotype of crd1Δ.
Cells were pre-cultured overnight in YPD at 300C, grown until an A550 of 1.0 in
YPD at 300C, washed with water, plated onto synthetic media without
glutamate and incubated at 370C and 390C as indicated for 3-5 days.
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was actually impaired in the mks1Δ strain, suggesting that Mksp1 is a positive
regulator of the RTG pathway. Consistent with an activator role, I observed
that the mks1Δ mutant, similar to the rtg1Δ, rtg2Δ, and rtg3Δ mutants, required
glutamate for growth in the BY4742 strain used in the current study (data not
shown). In addition, expression of the RTG target genes was impaired in
mks1Δ (data not shown) In summary, deletion of the negative regulator BMH2
rescued the glutamate auxotrophy of crd1Δ, while deletion of positive
regulators exacerbated the phenotype of the crd1Δ mutant.

Cells lacking CL cannot utilize acetate or oleic acid as sole source of
carbon
The glyoxylate cycle and β-oxidation pathways compensate for TCA cycle
deficiencies by supplying intermediates, as discussed above (Figure 4.2).
Oleic acid is broken down in peroxisomes by β-oxidation to supply acetyl-CoA
to the TCA cycle, or to supply TCA cycle intermediates by the glyoxylate
cycle. As mentioned, the RTG pathway is required for expression of CIT2, a
glyoxylate cycle gene, and for peroxisomal genes required for β-oxidation in
cells grown in oleic acid (Chelstowska and Butow, 1995). Therefore, RTG
mutants cannot utilize acetate or oleic acid as a sole source of carbon.
Consistent with our hypothesis that crd1Δ has defective RTG signaling, the
crd1Δ mutant, similar to RTG mutants, exhibits decreased growth on acetate
(Figure 4.9) or oleic acid media (Figure 4.10). The growth defects in acetate
are indications of TCA and glyoxylate cycle deficiencies, whereas inability of
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Figure 4.9: crd1Δ exhibits a growth defect on acetate. Cells were precultured overnight in YPD. WT, crd1Δ, and taz1Δ cells were plated on
synthetic media containing glucose and acetate as the sole source of carbon
and incubated at 300C for 6 days.

99

Figure 4.10: crd1Δ exhibits a growth defect on oleic acid. Cells were precultured in YPD until stationary phase at 300C. Cells were counted and
spotted on synthetic media containing glucose or oleic acid as the sole source
of carbon and incubated at 300C for 5-7days.
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crd1Δ cells to utilize oleic acid as a sole source of carbon (Figure 4.10)
indicates that the mutant may have a defect in 1) β-oxidation, 2) mitochondrial
uptake of acetyl-CoA generated by β-oxidation, or 3) uptake of TCA
intermediates synthesized by the β-oxidation pathway and the glyoxylate
cycle. Interestingly, the taz1Δ mutant grows normally (Figures 4.9 and 4.10)
suggesting that decrease in CL, aberrant CL species or increased MLCL
levels, as observed in taz1Δ, are sufficient to support growth on acetate or
oleic acid media. These results are consistent with the hypothesis that cells
lacking CL exhibit a defective RTG pathway.
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Discussion

The experiments in this study support the hypothesis that the loss of
CL leads to defective activation of the RTG pathway at elevated temperature.
Consistent with an RTG defect, the RTG target gene CIT2 is not upregulated,
and crd1Δ cells exhibit glutamate auxotrophy at elevated temperature.
Temperature sensitivity of the crd1Δ mutant was rescued by overexpression
of RTG2, a positive regulator of the RTG pathway, and by deletion of BMH2, a
negative regulator of the RTG pathway. Furthermore, crd1Δ cells exhibit
growth defects on acetate or oleic acid media, indicating a defect in the
glyoxylate cycle and β-oxidation pathways, which require the RTG pathway
for activation. Taken together, these results indicate that perturbation of the
TCA cycle in crd1Δ cells cannot be alleviated due to a defective activation of
the RTG pathway.
Deletion of BMH2, a negative regulator of the RTG pathway rescued
the glutamate auxotrophy of the crd1Δ mutant at elevated temperature (Figure
4.8). In addition to its role in the RTG pathway, Bmh2p, interacts with several
phosphorylated proteins that regulate cell signaling pathways, stress
response pathways, the cell cycle, and chitin synthesis at the cell wall
(Kakiuchi et al., 2007). Interestingly, the Greenberg lab has shown that the
crd1Δ mutant has defects in the stress response pathway, cell wall synthesis,
and the cell cycle (Chen et al., 2010b; Zhong and Greenberg, 2005; Zhou et
al., 2009). This suggests the possibility that Bmh2p might not only affect the
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activation of the RTG pathway but also affect these other pathways, which are
deficient in the crd1Δ mutant.
A decrease in the mitochondrial membrane potential is believed to be
the signal for activation of the RTG pathway (Miceli et al., 2011), which is
probably sensed by Rtg2p (Jazwinski and Kriete, 2012). Although a
decreased membrane potential was observed in crd1Δ (Jiang et al., 2000) the
RTG pathway was not triggered at elevated temperature. This suggests that
the signal for activation of the RTG pathway is not relayed in crd1Δ cells, and
that Rtg2p may be defective in the crd1Δ mutant. Consistent with this,
overexpression of Rtg2p rescued the ts phenotype of crd1Δ cells (Figure 4.3).
In mammalian cells, NFκB is believed to be a master regulator of the
RTG response that senses mitochondrial dysfunction (Liu and Butow, 2006),
a role similar to Rtg2p in yeast. NFκB modulates the expression of nuclear
encoded genes (Cogswell et al., 2003) via activation of the Myc-Max
heterodimer, a homolog of the RTG1-RTG3 heterodimer (Jazwinski and
Kriete, 2012). Thus, identifying the mechanism of RTG regulation in crd1Δ
may facilitate understanding of CL function in NFκB mediated signaling in
mammalian cells.
As discussed earlier, the TCA cycle is required for the biosynthesis of
many metabolites, including amino acids such as glutamate, arginine,
methionine and lysine. Recent studies from the Greenberg lab have shown
that CL deficient cells are auxotrophic for methionine and lysine (Vinay Patil,
unpublished) as well as for glutamate (Figure 4.6). Interestingly, amino acids
have been used as supplements to treat BTHS patients, with a positive
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outcome (Richard Kelly, unpublished). We anticipate that elucidating the
metabolic deficiencies in crd1Δ cells will contribute to our understanding of
similar deficiencies observed in BTHS. The restoration of deficient metabolites
will offer potential new treatments for this disorder.
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CHAPTER 5

FUTURE DIRECTIONS

The studies described in this thesis show exciting new roles of CL in diverse
mitochondrial functions, including protein import, fusion and RTG pathway
regulation. While my findings have shed some light on the mechanisms
underlying the cellular functions of CL, I feel that they have uncovered just the
tip of the iceberg. In this chapter, I suggest fascinating as well as challenging
new directions for future studies that could lead to a better understanding of
the mechanisms underlying CL function.
1.

CL and mitochondrial protein import: CL plays vital roles in the

mitochondrial inner membrane, including assembly of protein complexes,
(Claypool, 2009; Claypool et al., 2006; Claypool et al., 2008; Pfeiffer et al.,
2003), mitochondrial protein import, and membrane potential (Jiang et al.,
2000; Kutik et al., 2008; Tamura et al., 2009). Based on the genetic
interaction of CL mutants with the TOM, SAM and MDM complex mutants, I
hypothesized that CL plays a role in outer membrane protein biogenesis. As
CL is synthesized and is predominantly present in the mitochondrial inner
membrane, it was exciting to identify a function of CL in the biogenesis of
outer membrane protein complexes required for mitochondrial protein import
(Chapter 2). Importantly, CL is required for import not only in yeast. We also
showed a role of CL in assembly of outer membrane complexes in humans
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(Gebert et al., 2009). This is the first finding in humans that links CL to
mitochondrial protein import.
While we have established the function of CL in mitochondrial protein
import at the outer as well as inner membrane (Chapter 2), the implication of
defective protein import in CL deficient cells is unknown. A large-scale
proteomic study to compare the mitochondrial proteins in crd1Δ and WT cells
would identify the proteins that are not imported into mitochondria lacking CL.
Although this may seem challenging, it is both doable (as there are only ~600
to 700 mitochondrial proteins in yeast) and promising, as it may greatly
facilitate the identification of specific mitochondrial metabolic deficiencies
observed in crd1Δ cells (Chapter 4). Furthermore, it will be fascinating to
elucidate the role of a mitochondrial lipid in the regulation of basic metabolic
pathways.
A complementary approach to determine the consequences of
defective protein import in CL deficient cells is to identify suppressors of the
genetic interactions identified between mitochondrial protein import mutants
and CL mutants (Chapter 2). Suppressor mutations may fall into a number of
categories, including those that increase mitochondrial protein import, that
increase the amount of an essential protein that is limiting, and/or that have a
decrease in the accumulation of a toxic product that leads to the defective
growth phenotype.

2.

CL and mitochondrial morphology: The study described in Chapter

2 utilized a genetic interaction screen to identify the functions of CL in
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mitochondrial morphology. Genetic interaction was determined based on the
phenotype of the double mutant (crd1Δ and mitochondrial morphology
mutant). While several categories were uncovered, I draw future students’
attention to two in particular, the UPS and GET complexes. An interesting
finding pertinent to the regulation of CL synthesis is that crd1Δ is synthetically
lethal with ups1Δ (Figure 2.3). Other studies have reported that the UPS
complex (Ups1p and Ups2p) is required for regulating CL levels (Osman et
al., 2009a; Tamura et al., 2009). Why is crd1Δ synthetically lethal with ups1Δ?
How do UPS proteins regulate the levels of CL in the mitochondria? Answers
to these intriguing questions would clarify how Ups1p regulates CL synthesis.
While UPS proteins are present in mitochondria, GET proteins (Get1p
and Get2p) are present in the ER membrane. I showed that crd1Δ is
synthetically sick with get1Δ and get3Δ, which suggests that CL shares
functions with GET proteins. It was surprising to find genetic interaction of a
mitochondrial lipid mutant with the ER mutants. The GET proteins are
required for targeting proteins into the ER membrane (Schuldiner et al., 2008).
It is interesting to speculate that CL may be involved in targeting proteins to
the ER membrane, especially given the fact that ER and mitochondrial
membranes are tightly connected (Kornmann et al., 2009).
Decreased levels of CL observed in the get2Δ mutant point to another
interesting question. In addition to its role in protein targeting, does Get2p also
play a role in lipid transfer from the ER to the mitochondria? The mechanism
of lipid transfer from ER to mitochondria is not known. It is possible that GET
proteins might transfer lipids from the ER to the mitochondria by creating
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ERMES-like contact sites (Kornmann et al., 2009). Future work focusing on
these questions may reveal very interesting connections between ER and
mitochondria.

3.

CL and mitochondrial fusion: Chapter 3 describes the function of CL

in mitochondrial fusion in yeast. The loss of CL in yeast does not lead to a
defect in the mitochondrial tubular structure, although in vitro studies reported
that CL is required for the assembly and activity of the fusion protein Mgm1p.
Based on earlier findings that the loss of both CL and PE is lethal (Gohil et al.,
2005), I hypothesized that PE might compensate for CL in mitochondrial
fusion. Indeed, my studies showed that loss of both PE and CL leads to
mitochondrial fragmentation due to a fusion defect (Joshi et al., 2012). It will
be fascinating to study if the loss of mitochondrial PE and CL leads to
structural defects in other cellular organelles such as ER, vacuole, and
peroxisomes. These findings would suggest that PE and CL might be required
for cross talk between cellular organelles.
While the studies in Chapter 3 address a shared function of CL and
mitochondrial PE, they do not answer the question of why the loss of both is
lethal. Answering this question would identify essential mitochondrial as well
as non-mitochondrial functions of these phospholipids. The “awesome power
of yeast genetics” can be used to isolate suppressors of crd1Δpsd1Δ lethality,
which would lead to the identification of essential functions that are missing in
crd1Δpsd1Δ cells.
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4.

CL and the mitochondrial RTG pathway: In Chapter 4, I discussed a

fascinating new role of CL in activation of the RTG pathway. While decreased
mitochondrial function leads to activation of the RTG pathway in WT cells,
crd1Δ cells, which have decreased mitochondrial function, fail to activate the
RTG pathway at elevated temperature. This is the first report to show that a
phospholipid be might required for activation of the RTG mediated signaling
pathway. I reported in Chapter 4 that the key RTG target CIT2 is not
upregulated in crd1Δ cells (Figure 4.6B). Consistent with this, temperature
sensitivity of crd1Δ is rescued by 1) overexpression of RTG2 (Figure 4.3), a
positive regulator of the RTG pathway, 2) deletion of BMH2 (Figure 4.5), a
negative regulator of the RTG pathway, and 3) supplementation with
glutamate (Figure 4.6). All these findings indicate that activation of the RTG
pathway is defective.
Why do cells lacking CL have a defect in activation of the RTG
pathway? One possible reason involves the interplay between the positive
and the negative regulators of the RTG pathway. Rtg3p phosphorylation may
be perturbed in crd1Δ cells. Rtg2p activity may be defective in the mutant.
Alternatively, protein levels of the negative regulators may be elevated in
crd1Δ cells. A second possibility is that altered levels of TCA cycle
intermediates in the CL mutants lead to decreased expression of CIT2. At
least two possible mechanisms can alter the levels of TCA intermediates in
crd1Δ cells. First, decreased activities of TCA cycle enzymes such as
aconitase and succinate dehydrogenase (SDH), as seen in crd1Δ cells (Vinay
Patil, unpublished) could lead to decrease TCA intermediates. Second,
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decrease in TCA cycle intermediates in mitochondria may result from
decreased activity of transporters present in mitochondrial membranes.
Transporters such as Crc1p (carnitine), Sfc1p (succinate-fumarate), Ctp1p
(citrate), and Odc1p (α-ketoglutarate) are required to shuttle metabolites
across the mitochondrial membranes. CL might affect the activity of the
transporters in the membrane, causing an accumulation of the TCA cycle
intermediates in the mitochondria. An accumulation of metabolites such as
succinate in the mitochondria has been shown to inhibit the expression of
CIT2 (Lin et al., 2011). It will be interesting to check if accumulation of other
metabolites in the mitochondria has a similar effect on expression of CIT2.
Based on these observations, I hypothesize that the loss of CL leads to
defective shuttling of TCA cycle intermediates across the mitochondrial
membranes due to decreased activity of metabolite transporters, culminating
in feedback inhibition of CIT2 expression.
Another interesting possibility is that the loss of CL can lead to
decreased activity enzymes in the glyoxylate cycle, and β-oxidation pathway
that cannot be alleviated by activation of the RTG pathway. Consistent
glyoxylate and β-oxidation defects, the crd1Δ mutant is unable to utilize
acetate or oleic acid as a sole source of carbon (Figure 4.9 and 4.10). The
enzymes for these pathways are localized in peroxisomes. Interestingly, a
significant amount of CL (7% of total phospholipids) is present in the
peroxisomal membrane (Zinser et al., 1991) Therefore, CL deficiency may
lead to decreased activities of enzymes in this organelle. It is possible that
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blocks in these pathways could lead to metabolic deficiencies in crd1Δ cells
that are not alleviated by activation of the RTG pathway.
I challenge my colleagues in the Greenberg lab to address these
questions, the answers to which will facilitate our understanding of the role of
CL in the mitochondrial RTG pathway and in pathways replenishing the TCA
cycle.

5.

What makes CL research exciting? A great deal remains to be

learned about the uniqueness of CL. As discussed above, questions
regarding the function of CL in mitochondrial protein import, mitochondrial
morphology and the RTG pathway remain unanswered. What makes this
study exciting? First, because these functions are conserved and have direct
implications for human disorders, answering these questions will have
important implications not just for BTHS, but also for other disorders in which
CL plays a role. Second, we can use the simple yeast model system to
elucidate the link between the functions of a lipid to regulation of basic
metabolic pathways. Third, imagine that we identify metabolites that are
deficient in CL mutants. Can we then use this knowledge to cure CL related
disorders such as BTHS simply by supplementing metabolites as nutrients,
saving patients from more harsh treatments? This is what excites me about
CL research. I hope you are excited too. I wish all the success to the folks in
the Greenberg lab for their future work. Cheers!
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Cardiolipin (CL) is an anionic phospholipid synthesized in the
mitochondrial inner membrane. Perturbation of CL metabolism leads to Barth
syndrome (BTHS), a life threatening genetic disorder. I utilized genetic,
biochemical and cell biological approaches in yeast to elucidate the cellular
functions of CL. Understanding the functions of CL is expected to shed light
on the pathology and possible treatments for BTHS.
BTHS is caused by mutations in TAZ1, which encodes a CL
remodeling enzyme called tafazzin. BTHS patients exhibit a wide range of
clinical presentations, indicating that physiological modifiers influence the
BTHS phenotype. A targeted synthetic lethality screen was performed to
identify physiological modifiers of CL deficiency. Using this approach,
synthetic genetic interactions of CL mutants were identified with genes
encoding mitochondrial outer membrane proteins, specifically in the TOM,
MDM and SAM complexes, which are involved in mitochondrial protein import,
suggesting that CL plays a role in this process. Consistent with this, we
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showed that CL is present in the outer mitochondrial membrane and is
involved in assembly of outer membrane protein complexes in yeast as well
as in BTHS lymphoblasts. In addition to this, we showed that CL mutants
interacted with genes encoding mitochondrial protein import complexes of the
inner membrane, including the TIM and PAM complexes. To identify the role
of CL in maintaining mitochondrial morphology, a targeted synthetic lethality
screen was performed to determine if CL mutants genetically interacted with
mutants defective in this function. The crd1Δ mutant genetically interacted
with genes required for mitochondrial fusion and fission, suggesting a
common cellular function. In addition to genes involved in mitochondrial
fusion, crd1Δ genetically interacted with the UPS and GET complex mutants
suggesting shared cellular functions with these as well. Unlike the UPS
complex, a role for the GET complex in CL metabolism is unknown. My
studies indicated that levels of CL were decreased in the get2Δ mutant, thus
identifying a novel role of Get2p in the regulation of CL levels in yeast. In
summary, the genetic interaction studies identified functions that could be
physiological modifiers of CL deficiency in yeast, and could possibly point to
modifiers of the BTHS phenotype.
Based on the genetic interactions of CL mutants with mitochondrial
fusion mutants, we tested if CL plays a role in mitochondrial fusion. Because
the lack of CL does not lead to defects in the mitochondrial network in
Saccharomyces cerevisiae, I hypothesized that PE may compensate for CL in
the maintenance of mitochondrial tubular morphology and fusion. Previous
studies have shown that CL and mitochondrial PE have overlapping functions,
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and the loss of both is synthetically lethal. In the current study, we showed
that the loss of both CL and mitochondrial PE exhibited highly fragmented
mitochondria, loss of mitochondrial DNA, and reduced membrane potential,
characteristic of fusion mutants. Deletion of DNM1, required for mitochondrial
fission, restored the tubular mitochondrial morphology. Loss of CL and
mitochondrial PE led to reduced levels of small and large isoforms of the
fusion protein Mgm1p, possibly accounting for the fusion defect. Taken
together, these data demonstrate in vivo that CL and mitochondrial PE are
required to maintain tubular mitochondrial morphology and have overlapping
functions in mitochondrial fusion.
Recent studies have shown that cells lacking CL exhibit decreased
activities of the TCA cycle enzymes aconitase and succinate dehydrogenase.
Consistent with this finding, we showed that crd1Δ cells exhibit a growth
defect on acetate medium, consistent with a defect in the TCA and glyoxylate
cycles. A defect in the TCA cycle, and decreased mitochondrial functions,
leads to activation of the retrograde (RTG) pathway. While the crd1Δ mutant
exhibits these mitochondrial defects, it fails to activate the RTG pathway, as
the expression of CIT2 in crd1Δ is not upregulated at elevated temperature.
Consistent with the RTG defect, crd1Δ cells exhibit glutamate auxotrophy at
elevated temperature. We also find that overexpression of RTG2, a positive
regulator of the RTG pathway, and deletion of BHM2, a negative regulator of
the RTG pathway, rescues the ts phenotype of crd1Δ. The RTG pathway is
required for expression of genes that replenish TCA cycle metabolites. In
addition to the RTG pathway, the β-oxidation pathway can also compensate
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for the defect in the TCA cycle by replenishing intermediates such as acetylCoA. Interestingly, crd1Δ exhibits growth defects on oleic acid medium,
suggesting that cells lacking CL have a defect in the β-oxidation pathway.
Taken together, my studies suggest that CL mutants have defects in the TCA
and glyoxylate cycles and in the β-oxidation pathway, which cannot be
alleviated due to defective activation of the RTG pathway. Identifying the
function of CL in RTG signaling and metabolic pathways will facilitate
understanding of specific metabolic deficiencies in BTHS patients.
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